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Aerob høyintensitetstrening og kardiovaskulær helse 
Regelmessig fysisk aktivitet bedrer den fysiske formen, og er dokumentert å være en 
viktig bidragsyter med tanke på å redusere forekomsten av sykdom og dødelighet. 
Det maksimale oksygenopptaket, som er det beste målet på arbeidskapasitet, er vist 
å være en svært sterk indikator på dødelighet både hos friske og hos pasienter med 
hjerte-karsykdom. Regelmessig utholdenhetstrening for å øke maksimalt 
oksygenopptak er derfor anbefalt for bedret helse og økt livslengde. Selv om dette er 
etablert kunnskap, vet man lite om hvilken intensitet kondisjonstreningen bør 
gjennomføres med for å oppnå best mulig helsegevinst. 
Hensikten med denne doktorgradsavhandlingen var derfor å kartlegge hvilken 
intensitet i kondisjonstreningen som gir best effekt med tanke på å øke det 
maksimale oksygenopptaket blant pasienter med koronarsykdom. Vi ønsket også å 
studere hvorvidt intensiteten er viktig for å bedre fysisk form og redusere 
risikofaktorer for hjerte-karsykdom hos pasienter med metabolsk syndrom, som har 
en sterk opphopning av disse risikofaktorene. Derfor sammenliknet vi aerob 
intervalltrening med høy intensitet (80-90 % av maksimalt oksygenopptak) med 
kontinuerlig kondisjonstrening med moderat intensitet (50-60 % av maksimalt 
oksygenopptak) der total treningsmengde var lik. Videre ønsket vi å undersøke 
hvordan blodårenes funksjon og elastisitet ble påvirket av ulik type trening, både 
blant unge trente og utrente, og blant pasienter med metabolsk syndrom. 
Resultatene viste at trening med høy intensitet ga bedre effekter enn moderat 
intensitet for å bedre aerob kapasitet og redusere kjente risikofaktorer forbundet med 
hjerte-karsykdom, inkludert blodårefunksjonen. Avhandlingen kan derfor bidra med 
ny innsikt med tanke på bruk av aerob intervalltrening for mer effektivt å bedre 
kondisjonen og dermed helsen, både blant hjertesyke og hos individer med forhøyet 
risiko for fremtidig hjerte-karsykdom. 
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PREFACE
The study presented in this thesis was carried out at the Department of Circulation 
and Medical Imaging, Faculty of Medicine, Norwegian University of Science and 
Technology, and at the Department of Cardiology, St. Olavs Hospital, Trondheim 
University Hospital. The included original papers listed below are referred to by their 
roman number throughout the thesis. 
Paper I
High intensity aerobic interval exercise is superior to moderate intensity exercise for 
increasing aerobic capacity in patients with coronary artery disease. Ø Rognmo, EV 
Hetland, J Helgerud, J Hoff, SA Slørdahl. European Journal of Cardiovascular 
Prevention and Rehabilitation. 2004;11:216-222
Paper II
Endothelial function in highly endurance-trained and sedentary, healthy young 
women. IT Moe, H Hoven, EV Hetland, Ø Rognmo, SA Slørdahl. Vascular Medicine.
2005;10:97-102.
Paper III
Endothelial function in highly endurance-trained men: Effects of acute exercise.
Ø Rognmo, TH Bjørnstad, C Kahrs, AE Tjønna, A Bye, PM Haram, T Stølen, SA 
Slørdahl, U Wisløff. Journal of Strength and Conditioning Research. 2008;22:535-
542.
Paper IV
Aerobic interval training vs. continuous moderate exercise as a treatment for the 
metabolic syndrome - “A Pilot Study”. AE Tjønna, SJ Lee, Ø Rognmo, T Stølen, A 
Bye, PM Haram, JP Loennechen, QY Al-Share, E Skogvoll, SA Slørdahl, OJ Kemi, 
SM Najjar, U Wisløff. Circulation. 2008;118:346-54. 
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DEFINITIONS 
Physical activity: Any bodily movement produced by skeletal muscles that result in 
energy expenditure beyond resting expenditure. 
Physical fitness: Includes cardiorespiratory fitness, muscle strength, body 
composition, and flexibility, comprising a set of attributes that people have or achieve 
that relates to the ability to perform physical work. 
Cardiorespiratory endurance: The ability to perform dynamic large-muscle, whole 
body exercise at moderate to high intensities over a longer period
Exercise training: A subset of physical activity that is planned, structured, repetitive, 
and purposeful in the sense that improvement or maintenance of physical fitness is 
the objective.
Maximal oxygen uptake (VO2max): The highest rate at which oxygen can be taken 
up in the body during strenuous dynamically exercise with large muscle groups. It is 
considered the best measure of cardiorespiratory endurance since it sets the upper 
limit of aerobic capacity. 
Aerobic capacity: Equivalent to VO2max.
Cardiovascular disease (CVD): Diseases of the heart and the circulatory system. 
Coronary artery disease (CAD): The accumulation of atheromatous plaques within 
the walls of the arteries that supply the myocardium. 
Metabolic syndrome: The clustering of risk factors for cardiovascular disease. The 
most common combinations of risk factors found among patients with the syndrome 
are obesity, impaired glucose tolerance or insulin resistance, hypertension, 
dyslipidaemia and low HDL-cholesterol. 
Flow-mediated dilatation (FMD): Reactive hyperaemia-induced increase in blood 
flow and shear stress that causes dilatation that can be quantified as an index of 
endothelial function.
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ABBREVIATIONS
ATP  Adenosine triphosphate 
BH4   Tetrahydrobiopterin 
BMI  Body mass index 
BSA  Body surface area 
CABG  Coronary artery bypass graft surgery 
CAD  Coronary artery disease 
CaM  Calmodulin 
cGMP  Cyclic guanosine monophosphate 
CHD  Coronary heart disease 
CI  Confidence interval 
CVD  Cardiovascular disease 
ECG  Electrocardiogram 
EDHF  Endothelial derived hyperpolarising factor 
eNOS  Endothelial nitric oxide synthase 
EPC  Endothelial progenitor cell 
FMD  Flow-mediated dilatation 
GC  Guanylate cyclase 
GTN  Glycerol trinitrate 
H+  Hydrogen ion 
HDL  High density lipoprotein 
HRmax  Maximal heart rate 
LDL  Low density lipoprotein 
L-NAME L-nitroarginine methylester 
L-NMMA L-NG-monomethyl arginine 
NADPH Nicotinamide adenine dinucleotide phosphate 
NO  Nitric oxide 
PCI  Percutaneous coronary intervention 
RER  Respiratory exchange ratio 
VEGF  Vascular endothelial growth factor  
VO2max Maximal oxygen uptake 
WHO  World health organisation 
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INTRODUCTION
Diseases of the heart and the circulatory system (cardiovascular disease or CVD) are 
the leading cause of death in Europe with 4.3 million deaths per year (1). Despite a 
general declining trend in CVD mortality in Western, Northern and Southern 
European countries the last years, CVD still causes nearly half (48%) of all European 
deaths. Just under half of all deaths from CVD are from coronary artery disease 
(CAD) and nearly one third is from stroke (1). The CVD mortality rate in Norway has 
decreased the past decades with the percentage share of CVD mortality declining 
from 46% in 1991 to 35% in 2005 (2), probably due to improved medical and surgical 
treatment (3). Today we know that physical activity is an effective contributor for 
reducing both total and CVD mortality disease, and should therefore play a natural 
part of everyday life (4-6). 
Exercise and health 
Regular physical activity involving large muscle groups produces cardiovascular 
adaptations that increase physical fitness. Higher levels of physical activity and 
fitness are known to reduce both all-cause mortality and CVD mortality (4-11). 
Physical exercise is thus strongly recommended in both primary and secondary 
prevention of CVD (12-16). In addition to reducing mortality, there is also evidence 
that increasing physical fitness will improve health (17) and reduce the risk of a 
number of chronic diseases such as CVD (18), type 2 diabetes (19), osteoporosis 
(20), obesity (21), depression (22) and cancer of the breast and colon (23).
Cardiorespiratory endurance 
Cardiorespiratory endurance is one of the fundamental components of physical 
fitness (24) and has been defined as the ability to dynamically perform large-muscle, 
whole body exercise at moderate to high intensities over a longer period (25). The 
three major factors limiting cardiorespiratory endurance are maximal oxygen uptake, 
lactate threshold and work economy (25,26). To increase endurance performance 
one have to increase at least one of these factors. 
Maximal oxygen uptake 
The oxygen uptake is a measure of aerobic energy turnover in the body, and reflects 
the capacity to transport and utilise oxygen, i.e. the functional capacity of the lungs, 
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cardiovascular system and muscle mitochondria combined (27). Maximal oxygen 
uptake (VO2max) is defined as the highest rate at which oxygen can be taken up in the 
body during severe exercise with large muscle groups (28). It is considered as the 
best measure of cardiorespiratory endurance since it sets the upper limit of aerobic 
capacity (29). VO2max is the product of oxygen delivery and arteriovenous oxygen 
difference. In both athletes and healthy individuals VO2max is limited by the ability of 
the cardiorespiratory system to supply the working muscles with oxygen (27-32). It is 
important to emphasise that each and every step in the oxygen supply pathway from 
the lungs to the mitochondria contributes to determine VO2max but that the major 
influence is set by cardiac output, or more precisely stroke volume since maximal 
heart rate is fixed (27,28). However, untrained individuals and patients may be limited 
by the metabolic demand of the muscle mitochondria and it is suggested that 
exercise training may induce a switch from demand to supply limitation of VO2max
(33).
Lactate threshold 
During exercise with continuously increasing power output, lactate production will 
reach a point where lactate release into the blood rises faster than the clearance 
mechanisms in muscle and other tissues can accommodate. This inflection point in 
blood lactate level is named the lactate threshold and determines the fraction of VO2
that may be sustained for an extended period of time (34). The main factors 
responsible for lactate accumulation appear to be recruitment of fast-contracting 
muscle fibers, secretion of hormones that accelerate glycogenolysis and glycolysis, 
and a redistribution of blood flow from lactate-removing tissues to lactate-producing 
tissues (34).
Work economy 
Work economy is defined as the oxygen uptake needed to work at a given intensity 
(25). Task specific endurance training will improve work economy (35). Interestingly, 
also maximal strength training has shown to improve work economy in endurance 
events, because an increase in maximal strength will lead to improved 
neuromuscular characteristics of the working muscles, which save oxygen during 
submaximal work (36-38).
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Aerobic exercise training responses 
Aerobic exercise training improves cardiorespiratory endurance by inducing changes 
in both oxygen transport and utilisation. Maximal oxygen delivery increases after 
aerobic training due to an increase in stroke volume, myocardial contractility and 
blood volume (39-41). Also, the arteriovenous oxygen difference in the skeletal 
muscles improves due to increases in mitochondrial density, oxidative enzyme 
concentration, capillary density, myoglobin- and glycogen concentration 
(15,29,34,42).
Health effects of improved aerobic capacity 
Cardiovascular disease 
Aerobic exercise training has special significance for individuals with CVD because 
the exercise-induced changes promote lower myocardial oxygen demand at any 
given workload. These include reduced heart rate, lower systolic blood pressure, and 
decreased amount of circulating catecholamines (15). The benefits of these 
adjustments can be demonstrated by the greater amount of work that can be done 
before angina pectoris and/or ischemic ST depression occurs. Also, myocardial 
perfusion has been found to improve after aerobic exercise training among these 
patients (43,44). Individuals who participate in regular physical exercise possess a 
lower prevalence of cardiovascular risk factors such as hypertension (45), type 2 
diabetes (19), obesity and  hypercholesterolemia (46), and aerobic exercise is 
therefore considered an important adjuvant therapy in risk factor modification (16). 
Peak aerobic exercise capacity is found to be a strong, independent predictor of both 
cardiac- and all-cause deaths among both healthy individuals and those with CVD 
(47-52). These findings indicate that increasing exercise capacity should make a 
difference not only in functional capacity but also in survival prognosis. In fact, in both 
healthy subjects and those with CVD, the peak exercise capacity is shown to be a 
stronger predictor of increased risk of death compared to the established risk factors 
hypertension, obesity, smoking and type 2 diabetes (48). An important aspect is that 
poor physical fitness is a modifiable risk factor, and improvements in aerobic capacity 
has shown to reduce the risk of death (53). 
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In addition to prospective epidemiological studies, several meta-analyses have 
concluded that cardiac rehabilitation involving exercise reduces mortality rates in 
CAD patients (9-11). In the most recent meta-analysis, 48 randomized controlled 
trials of exercise-based cardiac rehabilitation were included (54). The studies 
included 8940 men and women of all ages. Studies were considered eligible if they 
were randomised controlled trials with follow-up of six months or more, with 
supervised or unsupervised exercise training of at least six months duration. Patients 
were included if they had sustained a myocardial infarction, had undergone coronary
artery bypass grafting or percutaneous coronary intervention (PCI), had angina 
pectoris, or had CAD identified by angiography. Cardiac rehabilitation was associated 
with 20% reduced all-cause mortality and a 26% reduction in cardiac mortality. There 
was no difference in mortality between exercise-only cardiac rehabilitation and 
comprehensive cardiac rehabilitation, or by exercise dose or duration of follow-up 
(54). Exercise is thus associated with 20-26% decreased risk of mortality, i.e. a 
magnitude similar to that associated with antihypertensive and lipid lowering 
interventions (55,56). 
Although several studies have shown a significant inverse relationship between 
participation in rehabilitation programmes involving exercise and reduced progression 
of CVD (57-61), data establishing which exercise-intensity that yields maximal 
beneficial adaptations are scarce. For health promotions, patients with CVD are 
recommended to regularly exercise at intensities ranging from 40-85% of VO2max (12-
15,62). The Norwegian Directorate of Health recommends all adults to perform a 
minimum of 30 minutes of physical activity every day, at moderate to high intensity 
(63). However, aerobic exercise training programmes are most often carried out at 
low- to moderate intensities (64). Both walking and vigorous exercise have been 
found equally effective in increasing aerobic capacity and reducing cardiovascular 
event risk (65,66). However, two large cohort studies found that higher intensity of 
physical activity was related to reduced cardiovascular risk, as reflected by an 
inverse association between exercise intensity and coronary heart disease incidence 
in men (67,68). 
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Metabolic syndrome 
The clustering of several metabolic and cardiovascular disease risk factors has been 
termed the metabolic syndrome. It is a common metabolic disorder that results from 
the increasing prevalence of obesity (69,70). When grouped together the risk factors 
are associated with increased risk of cardiovascular disease (71). Interestingly, a 
study by Wisløff et al. (72) demonstrated that after 11 generations of breeding of rats 
selected on low and high intrinsic exercise capacity, rats with low aerobic capacity 
scored high on cardiovascular risk factors that constitute the metabolic syndrome, i.e. 
linking reduced fitness to cardiovascular and metabolic disease. Several definitions of 
the metabolic syndrome are in use, but the most common combinations of risk 
factors found among individuals with the syndrome are obesity, impaired glucose 
tolerance or insulin resistance, hypertension, dyslipidaemia and low HDL-cholesterol 
(73). In order to overcome the problems related to the definition of the metabolic 
syndrome, a WHO working group in 1998 suggested a working definition of the 
metabolic syndrome. The WHO criteria of the syndrome (74) are shown in table 1. 
Also, In 2006, a new world wide definition was created so that data from different 
countries more easily could be compared (75). 
Table 1. WHO definition of the metabolic syndrome. 
Glucose intolerance or diabetes and/or insulin resistance 
+ 2 of the following: 
Obesity; BMI >30 kg/m2 and or waist-to hip-ration >0.9 (ƃ) or >0.85 (Ƃ)
Dyslipidaemia; triglycerides >1.7mmol/l and/or HDL cholesterol <0.9 (ƃ), <1.0 (Ƃ)
Hypertension; Blood pressure >140/90 and/or medication 
Microalbuminuria; albumin excretion >20µg/min 
Lakka et al. (76) reported that middle-aged Finnish men diagnosed with metabolic 
syndrome as defined by the WHO had 2.5 (CI: 1.3-4.8) times higher CVD mortality 
and 1.9 (CI: 1.2-2.9) times higher all-cause mortality over 11.6 years of follow-up than 
healthy men. The same conclusion was made by Katzmarkzyk et al. (77) who found 
that American men diagnosed with the metabolic syndrome were 1.3 (CI: 1.1-1.6) 
times more likely to die of any cause and 1.9 (CI: 1.4-2.6) times more likely to die of 
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CVD than healthy men after adjustment for age, year of examination, smoking status, 
alcohol consumption, and parental CVD. They also found that higher levels of 
cardiorespiratory fitness attenuated the mortality risk as there was a substantially 
lower risk in fit men than in unfit men (77). The finding of a dose-response 
relationship between fitness and mortality indicate that physical activity may be a 
valuable treatment of the metabolic syndrome. The positive influence of aerobic 
exercise on metabolic syndrome in humans was shown by Katzmarkzyk et al. (78) 
who exercised 105 patients for 20 weeks. After the aerobic exercise training period 
was finished, 30% of the participants were no longer classified as having the 
metabolic syndrome.
Also among children the prevalence of obesity is increasing rapidly (79). In a study 
including 82 overweight or obese children it was shown that the vascular dysfunction 
associated with obesity in children is partially reversible by 1 year of dietary 
modification (80). In a recent study by Tjønna et al. (81) it was found that three 
months of two weekly high-intensity aerobic exercise sessions reduced several 
known cardiovascular risk factors, like endothelial dysfunction, VO2max, insulin, fasting 
glucose and fat mass more than that observed after a multi-treatment strategy in 
obese adolescents. In addition, 12 months follow-up confirmed that high-intensity 
aerobic exercise was superior of improving or stabilising these risk factors.
Safety of exercise 
Even if regular physical activity reduces coronary heart disease (CHD) events, 
vigorous activity can also acutely and transiently increase the risk of sudden cardiac 
death and acute myocardial infarction in susceptible persons (82-84). The risk of 
myocardial infarction during or soon after exertion is greater in persons who do not 
regularly participate in physical activity (83-85) and it is thus of great importance to 
get this sedentary group more active. The 2007 Scientific Statement from the 
American Heart Association on exercise and acute cardiovascular events (86) 
estimates one cardiac arrest per 116 906 patient-hours, one myocardial infarction per 
219 970 patient-hours, one fatality per 752 365 patient-hours, and one major 
complication per 81 670 patient-hours of exercise in CHD-patients. Hauer et al. (87) 
demonstrated that adherence to prescribed target heart rate up to 95% of maximum
(90% VO2max) reached during symptom-limited exercise testing is associated with 
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very few ischemic episodes even during high-intensity exercise training in stable 
CAD-patients. However, exercise testing should be performed at the discretion of a 
physician before vigorous exercise in patients with known cardiovascular problems 
(18), and more studies are needed for safety evaluation of high-intensity exercise. 
Endothelial function 
The vascular endothelium is the single layer of cells that form the inner lining of the 
cardiovascular system. It forms the biologic interface between circulating blood and 
the various organs of the body. Together with neural control, the endothelium is the 
major regulator of the vascular homeostasis by synthesising and releasing a number 
of biologically active factors involved in regulation of vascular tone and exerts 
anticoagulant, antiplatelet and fibrinolytic properties. The endothelial maintenance of 
vascular tone is accomplished by numerous vasodilators (e.g. nitric oxide (NO), 
endothelium-derived hyperpolarizing factor (EDHF), prostacyclin and bradykinin) and 
vasoconstrictors (e.g. endothelin-1 and angiotensin II) (88).  
NO is probably the most important endothelial-derived relaxing factor. It is 
synthesised from the amino acid L-arginine to NO and L-citrulline by the enzyme 
endothelial nitric oxide synthase (eNOS) which is located in caveolae in cell 
membranes (88,89) (Figure 1). NO exerts its relaxing effects on vascular smooth 
muscle cells following stimulation by either shear stress or endothelial agonists such 
as bradykinin or acetylcholine by activating guanylate cyclase which increase 
production of cyclic guanosine monophosphate (cGMP) and decrease intracellular 
calcium (90). In addition to relaxing smooth muscle, NO counteracts events or 
actions that promote atherosclerosis, such as vasoconstriction, platelet aggregation, 
smooth muscle cell proliferation and migration, leukocyte adhesion, and oxidative 
stress (91). Another important endothelial-derived relaxing factor is prostacyclin, 
which acts synergistically with NO to inhibit platelet aggregation and contributes to 
exercise-induced hyperaemia (92,93). It seems that prostacyclin is a particularly 
important regulator of metabolic vasodilatation in patients with atherosclerosis, i.e. 
when NO production is reduced (94,95). EDHF is also known to be released by 
endothelial cells in response to shear stress but little is known about its physiological 
significance in humans (96).  
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Figure 1. Production of NO by endothelial cells. NO is produced by the action of eNOS on L-
arginine. This reaction requires a number of cofactors, including tetrahydrobiopterin (BH4) and 
nicotinamide adenine dinucleotide phosphate (NADPH). Increased intercellular Ca2+ in response 
to vasodilator agonists or shear stress displaces the inhibitor caveolin from calmodulin (CaM), 
activating eNOS. NO diffuses to vascular smooth muscle and causes relaxation by activating 
guanylate cyclase (GC), thereby increasing intracellular cyclic guanosine monophosphate 
(cGMP). Reprinted from Davignon and Ganz. Circulation 2004;109(23 Suppl 1):III27-32. 
Endothelin-1, the most prominent vasoconstrictor secreted by the endothelium has 
been linked to the etiology of a number of cardiovascular diseases including 
hypertension, CAD and heart failure (97). Van Guilder et al. (98) demonstrated that 
endothelin-1 mediated vasoconstrictor tone also increases with age in healthy men, 
but can be alleviated with regular aerobic exercise. This suggests that in older and 
diseased populations both increased endothelin-1 levels together with decreased NO 
bioavailability may be responsible for the increased vascular tone (98,99). The 
sympathetic nervous system may also influence on vasoconstriction, at least in 
elderly. This was demonstrated by Thijssen et al. (100) who showed that older men 
had an impaired FMD response of the superficial femoral artery, which increased by 
local blunting of the sympathetic responsiveness, but remained unaltered during 
sympathetic activation. Wray et al. (101) suggest that an elevated angiotensin II type 
1 receptor sensitivity in healthy, older adults at rest may be particularly relevant to the 
progression of cardiovascular disease states, characterised by an elevation in both 
sympathetic nerve activity and angiotensin II. Exogenous angiotensin II-mediated 
vasoconstriction was however greatly reduced during isolated, small muscle mass 
exercise, indicating that exercise may play a role in counteracting the reduced 
vascular conductance with age. 
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Endothelial dysfunction 
Endothelial dysfunction occurs when the balance between vasoconstriction and 
vasodilatation is disturbed, causing damage to the arterial wall. Endothelial 
dysfunction is considered an early marker for atherosclerosis, preceding 
angiographic and ultrasonic evidence of atherosclerotic plaque (93) and may be 
present already in childhood (102). The vasomotor function of coronary and 
peripheral arteries depends on the interplay between eNOS-derived NO-production 
and NO-degradation by reactive oxygen species (ROS) (103,104). Under normal 
circumstances, ROS are produced in small amounts by a variety of enzymes and 
function primarily as signal molecules. In patients with CAD or with elevated risk 
factors, ROS are however produced in excessive amounts and has been shown to 
inactivate NO production. This may ultimately exhaust the protective effect of the 
endogenous, anti-inflammatory systems within the endothelial cells. As a 
consequence, the endothelium becomes not only dysfunctional, but the cells may 
also lose integrity, progress to senescence, and detach into the circulation (105). 
Emerging evidence suggests that a subset of bone marrow-derived endothelial stem 
cells, so-called endothelial progenitor cells (EPCs), can mobilize to the injury site and 
complement repair afforded by pre-existing endothelium (106). Hill et al. (107) 
showed that the degree of endothelial dysfunction correlated inversely with the 
number of EPCs, indicating that a possible mechanism for endothelial dysfunction 
may be caused by a relative deficiency of EPCs. 
Endothelial function assessment 
Endothelial function can be assessed invasively using acetylcholine, which acts via 
musacrinic membrane receptors to mediate release of NO. The endothelium-
dependent vasodilator response may serve as a surrogate for the bioavailability of 
NO, and in healthy arteries endothelium-dependent dilatation predominates while in 
the presence of endothelial damage, vasoconstriction predominates (88,93). Also, 
infusion of other dilating compounds such as serotonin, bradykinin, adenosine and 
substance P have been used to provoke coronary or peripheral artery dilatation to be 
quantified by forearm plethysmography, coronary angiography or positron emission 
tomography (108).
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Ultrasound assessment of FMD of the brachial artery 
The most widely used technique today for detecting endothelial dysfunction is
noninvasively high-resolution ultrasound to assess brachial artery diameter dilatation 
(105,109). This test is considered the prime standard for clinical research on conduit 
artery endothelial biology (105). The brachial artery diameter is measured at baseline 
and after reactive hyperaemia produced by 5 minutes of upper or lower arm 
occlusion (102,110). The reactive hyperaemia induces increased blood flow and 
shear stress, stimulating NO-release and flow-mediated dilatation (FMD) that can be 
quantified as an index of endothelial function (110). Also prostacyclin, endothelin-1 
and EDHF may be released by the endothelium in response to shear stress (99,111). 
A small FMD-response to elevated shear stress is interpreted as indicating 
endothelial dysfunction and an associated increased risk of cardiovascular disease. 
This was demonstrated by Lieberman et al. (112) who found FMD of the brachial 
artery to be reduced in relatively young patients with CAD compared to healthy 
individuals. 
Relation between coronary and peripheral endothelial function 
The systemic nature of endothelial dysfunction is reflected by a relation between
coronary artery endothelium-dependent vasomotor responses to acetylcholine and 
the assessment of FMD induced by reactive hyperaemia in the brachial artery. 
Anderson et al. (113) observed a significant, but relatively low correlation (r = 0.36) 
between FMD in coronary and brachial arteries. Takase et al. (114) studied the 
relation between the two techniques and obtained a much stronger correlation (r = 
0.78) when adjusting for initial differences in diameter and flow ratio. Other studies 
have concluded that impairment of FMD in the brachial artery is closely related to 
both angiographic and myocardial perfusion imaging evidence of CAD (115,116). 
Thus, these data suggest that the noninvasive assessment of FMD in brachial 
arteries could be used as a surrogate measure for coronary artery endothelial 
function.
Prognostic impact of endothelial dysfunction 
Several studies in healthy individuals have shown a correlation between endothelial 
dysfunction and the presence of cardiovascular risk factors such as 
hypercholesterolemia, hypertension, smoking, diabetes and a positive family history 
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of premature CAD (117-121). The total number of risk factors has been found to be a 
potent predictor of endothelial dysfunction as measured both by the acetylcholine test 
in coronary arteries (118) and by the brachial artery ultrasound FMD test (121). 
Celermajer et al. (121) studied the superficial femoral and brachial artery in 500 
clinically well, non-hypertensive subjects. The results showed that reduced flow-
mediated dilatation was significantly related to hypercholesterolemia, cigarette 
smoking, higher blood pressure, male gender, older age, family history of premature 
vascular disease and larger blood vessel size. The authors concluded that loss of 
endothelium-dependent dilatation in the systemic arteries is associated with 
interaction of the same risk factors known to predispose to atherosclerosis and its 
complications later in life.  
Impaired coronary and brachial artery endothelial function predicts both long-term 
and short-term atherosclerotic disease progression and cardiovascular event rates 
including death (122,123). Schashinger et al. (124) found that impaired coronary 
artery vasodilator reactivity was associated with long-term atherosclerotic disease 
progression and cardiovascular event rates over 7.7 years follow-up. The coronary 
vasoreactivity showed to be a significant predictor of poor prognosis, even after 
adjustments for traditional risk factors or the presence of atherosclerosis. In the 
largest such study to date involving 308 patients, both epicardial and microvascular 
coronary endothelial dysfunction independently predicted acute cardiovascular 
events in patients with and without CAD over 3.8 year follow-up (125).
Like in the coronary arteries, impaired FMD measured by ultrasound in the brachial 
artery has also been found to be a predictor of future cardiac events. This was 
demonstrated in a study by Neunteufl et al. (126) who found that patients with chest 
pain and no angiographic evidence of CAD, heart failure or valvular defects, which 
showed impaired brachial artery FMD, were more likely to undergo PCI and coronary 
artery bypass surgery than patients with normal FMD during five years follow-up. In 
addition, Patti et al. (127) found that impaired FMD also predicted the occurrence of 
in-stent restenosis in patients undergoing PCI. Gokce et al. (128) examined brachial 
artery FMD in 199 patients with peripheral arterial disease 14 months after elective 
vascular surgery. The results showed that impaired endothelial function 
independently predicts long-term cardiovascular events in this patient group, and that 
17
noninvasive assessment of endothelial function using brachial artery FMD may serve 
as a surrogate end point for cardiovascular risk. Modena et al. (129) studied brachial 
artery FMD in post-menopausal women with newly diagnosed hypertension, and 
concluded that patients had increased risk over the next five years when endothelial 
function was not reversed by six months of antihypertensive therapy. Thus, 
endothelial dysfunction acts as a marker for patients with “preclinical” vascular 
disease and identifies patients in whom therapeutic intervention may be beneficial.
Even if the predictive value of brachial artery FMD for cardiovascular events is shown 
in several studies (126-133), it is not unambiguous established (134,135). A meta-
analysis by Witte et al. (136) found that the relation between brachial artery FMD and 
cardiovascular risk factors was affected by the baseline cardiovascular risk. Their 
results indicated that only in patients with low risk, brachial FMD is related to the 
principal cardiovascular risk factors and to an estimated 10 years risk of CAD.
Effects of aerobic exercise training on endothelial dysfunction 
Strategies that reverse endothelial dysfunction have important clinical applications in 
a variety of CVD states. Studies have shown that various interventions improve 
endothelial function including lipid-lowering therapy, antioxidant therapy, inhibition of 
angiotensin-converting enzyme or angiotensin II receptor blockade, smoking 
cessation, dietary interventions, and physical exercise (137-139). Aerobic exercise 
increases blood flow to the exercised limbs and myocardium, and the increased 
blood flow augment shear stress, which in the presence of normal endothelial 
function produces vasodilatation (111,140). The increased shear stress promotes 
vasodilatation by increasing the vascular expression of eNOS and thereby enhancing 
the release of NO (141,142). The preservation of endothelial integrity depends on the 
balance between injury and the endogenous capacity for repair, and the restoration 
of the equilibrium between NO production and inactivation by ROS appears to be a 
primary mechanism contributing to the exercise-mediated improvements of 
endothelial function (103). Circulating EPCs derived from the bone marrow also seem 
to play a key role in contributing to enhanced tissue perfusion (103), since EPCs are 
found to increase both after regular (143) and acute (144) exercise, increasing both 
FMD and vascular endothelial growth factor (VEGF). Indeed, Sandri et al. (145) 
demonstrated that repetitive episodes of ischemia during exercise training was 
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required to induce a sustained elevation of plasma VEGF concentrations and EPC 
counts in patients with peripheral artery occlusive disease. Also prostacyclin and 
EDHF contribute to exercise hyperaemia in humans, however in a more limited role 
(92,99,146). Together, all these substances have been shown to inhibit multiple 
processes involved in atherogenesis and to promote health (93).
Systemic effects of exercise 
It has been demonstrated that beneficial effects of exercise are not only confined to 
the trained extremity, but also induces a systemic effect on endothelial function 
(40,147). Regular aerobic exercise is thus an important non-pharmacological option 
to delay the decrease in endothelial function associated with ageing and has been 
found to reverse impaired endothelial function in individuals with atherosclerosis, 
hypertension, dyslipidaemia, type 2 diabetes and heart failure (148-154). However, a 
recent analysis of 27 000 subjects reported that differences in risk factors explained 
59% or less of the cardiovascular risk reduction with exercise (155). This indicate that 
direct systemic shear stress mediated effects on the endothelium also contribute to 
the reduction in cardiovascular events associated with large muscle-mass exercise 
training, since improvements in conduit and resistance vessel endothelial function are 
found to occur independent of changes in cardiovascular risk factors (156). Exercise 
thus seems to exert direct effects on the vasculature via the impact of repetitive 
increases in shear stress on the endothelium, which transduce functional and 
structural adaptations that decreases cardiovascular risk (157).
The beneficial effect of exercise on the endothelium was clearly demonstrated by 
Hambrecht et al. (158), who found that in patients with stable CAD and an 
angiographically documented stenosis amenable for PCI, a 12 months exercise 
training program resulted in a higher event-free survival rate than with standard PCI 
intervention. Interestingly, both PCI and exercise training were equally effective in 
improving symptom-free exercise tolerance. However, the exercise intervention was 
associated with higher exercise capacity and VO2max after 12 months than in the PCI 
group. In addition, the training intervention was found to be significantly more cost-
effective. The benefit of regular training was maintained at two years with a markedly 
better improvement of exercise capacity and better event-free survival in the training 
group (159). Moreover, our research group (40) demonstrated a systemic improved 
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effect on FMD measured in the brachial artery after 12 weeks of aerobic treadmill 
exercise in heart failure patients (Figure 2). The observed improvement was greater 
after high-intensity aerobic exercise compared to moderate intensity, and there was 
also a close relationship between improved aerobic capacity and improved FMD
(r = 0.69). 
Figure 2. Left, Endothelial function measured as FMD. Right, Maximal oxygen 
uptake. Data are mean±SD. Lines represent individual values. Probability 
values inside figures indicate within-group differences.  Aerobic interval 
training (AIT) different from control and moderate continuous training (MCT), 
P<0.01;  different from control, P<0.01. Reprinted from Wisløff et al. 
Circulation 2007;115:3086-94. 
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Athletes arteries 
Highly endurance-trained individuals are associated with increased arterial diameter 
compared to untrained (160). The size and blood flow of the proximal limb arteries 
thus seem to be adjusted to the metabolic needs of the corresponding extremity 
musculature. This emphasise the impact of exercise training or disuse on the 
structure and the function of the arterial system. Although evidence exists that 
aerobic exercise gives improved endothelial function when it is impaired 
(104,138,140), the influence in young healthy individuals and athletes is however 
less clear. It has previously been reported that exercise may enhance, decrease or 
have no effect on endothelial function in young, healthy individuals (161-163). Two 
studies have also suggested that high-intensity exercise may induce oxidative stress 
that may adversely affect endothelial function (162,164).
Effective exercise 
The question whether high-intensity exercise outmanoeuvres the possible adverse 
effects both in healthy individuals and in patients at cardiovascular risk remains to be 
further clarified. As aerobic exercise capacity seems to reflect a continuum between 
health and cardiovascular disease and death, it is important to design effective 
training programmes that effectively contribute to promote health. As consensus 
about the most efficient exercise mode to improve health is lacking, the effect of 
aerobic exercise at different intensities needs to be further elucidated. 
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AIMS OF THE STUDY 
The main purpose of the study presented in this thesis was to study cardiovascular 
adaptation to aerobic exercise of either high- or moderate intensity, in trained and 
untrained young persons, in CAD-patients, and in individuals with the metabolic 
syndrome. More specific, we wanted to determine what exercise intensity is the most 
effective for increasing aerobic capacity in CAD-patients and for reducing the 
cardiovascular risk factors in individuals with the metabolic syndrome. We also 
wanted to evaluate how endothelial function is affected by both acute and chronic 
exercise among individuals with different aerobic capacity and cardiovascular risk. 
The specific aims were: 
I. To determine if high- or moderate exercise intensity is most effective for 
increasing VO2max in CAD-patients. We hypothesised that interval exercise 
at high intensity is superior to continuous exercise at moderate intensity for 
increasing VO2max.
II. To evaluate brachial artery FMD and diameter in highly endurance-trained 
females compared to untrained females. We hypothesised that endothelial 
function is well preserved among sedentary, healthy females and that a 
high training status will not improve the dilating capacity any further. 
III. To evaluate the influence of high vs. normal aerobic capacity and a single 
bout of interval exercise at high intensity on arterial diameter, peak blood 
flow, brachial artery FMD, bioavailability of NO, and antioxidant status in 
well-trained and untrained young men. We hypothesised that athletes 
would have larger arterial diameter but similar endothelial function 
compared to untrained, and that one high intensity exercise session would 
not impair endothelial function in either group. 
IV. To determine the optimal level of exercise intensity needed to treat the 
metabolic syndrome and its associated cardiovascular abnormalities. We 
hypothesised that high intensity exercise is more effective than continuous 
moderate exercise to reverse features of the metabolic syndrome.
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MATERIALS AND METHODS 
Subjects
Study I 
Twenty-one participants with angiographically documented CAD in at least one major 
epicardial vessel were enrolled in the study. In addition, subjects had clinical 
evidence of CAD in form of previous myocardial infarction, significant stenosis treated 
with coronary artery bypass graft surgery (CABG) or percutaneous coronary 
intervention (PCI), or ischemia in exercise-ECG. Eleven patients were randomly 
assigned to high-intensity exercise and 10 to moderate intensity exercise. Exclusion 
criteria were left main coronary artery disease, unstable angina pectoris, intermittent 
claudication, myocardial infarction within the last three months, CABG or PCI 
performed within the last 12 months, complex ventricular arrhythmias, left ventricular 
ejection fraction below 40%, orthopaedic or neurological limitations to exercise, or 
regular exercise for the past three months.
Study II 
Sixteen endurance-trained females and 14 females with no habit of exercise were 
recruited among university students. The athletes were cross-country skiers, track 
and field- or orienteering runners, and were recruited if they exercised regularly for a 
minimum of three times per week. None of the subjects were smokers, frequently 
passive smokers, pregnant or taking cardiovascular- or antioxidant medication. 
Subjects who had a history of diabetes, dyslipidaemia, hypertension, thyroid illness, 
or a family history of premature cardiovascular disease were excluded. Six of the 
endurance-trained and seven of the sedentary women were taking oral 
contraception.
Study III 
Ten highly endurance-trained male athletes (cross-country skiers, orienteering 
runners and biathlon skiers), all in the national team in their respective sport and 
within top ten on a national basis, and seven healthy sedentary males recruited 
among university students took part in the study. Inclusion criteria were a VO2max
either above 70 mL · kg-1 · min-1 for athletes or below 55 mL · kg-1 · min-1 and less 
than one hour of exercise training per week for controls. Exclusion criteria were 
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history of hypertension, diabetes mellitus and family history of premature 
cardiovascular disease.   
Study IV 
Twenty-eight patients with metabolic syndrome defined according to the WHO-criteria 
(74) took part in the study. Patients were randomised and stratified according to age 
and gender into a interval training group, a moderate training group or to a control 
group. Exclusion criteria were unstable angina, recent coronary arrest (within four 
weeks), heart failure, severe pulmonary disease, uncontrolled hypertension, kidney 
failure, orthopaedic and/or neurologic limitations, cardiomyopathy, pregnancy, drug or 
alcohol addictions, and participation in parallel studies. 
Testing procedures 
Testing of VO2max
All tests of VO2max were accomplished during uphill treadmill walking or running since 
this also was the exercise training mode. Uphill treadmill exercise offers advantage 
when training and testing humans since it recruits a larger muscle mass and a slower 
cadence, producing the highest oxygen uptake (29).
CAD and metabolic syndrome patients (study I and IV) 
For CAD and metabolic syndrome patients, all VO2max-tests were accomplished using 
MetaMax II portable system (Cortex, Leipzig, Germany). To familiarise with treadmill 
walking, the VO2-test started on a flat treadmill learning to walk without grasping the 
handrails. As soon as the patients were walking properly, the speed and inclination 
were individually adjusted for a 10 minute warm-up. After the warm-up period, the 
VO2max-test was completed using an individually adjusted ramp protocol increasing 
both treadmill speed and inclination. For CAD-patients a standard 12-lead ECG was 
recorded at rest and at the end of each work level. The intention of the individually 
adjusted protocol was to bring the subjects to VO2max after approximately 8-12 
minutes (165). The average of the three highest 10 seconds measurements was 
determined VO2max. Heart rate was continuously recorded using Polar Sport Tester 
(Polar Electro OY, Finland) and maximum heart rate (HRmax) was determined.
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Considerations of VO2max-measurements in CAD-patients (study I) 
To ensure that exercise is conducted at the proper intensity, it is important that 
patients are exercising to their maximal effort on the initial VO2max-test. If not, the 
reported exercise intensities are likely underestimates of the actual ranges. A plateau 
of oxygen uptake despite increased work load and a respiratory exchange ratio 
(RER) above 1.05 were used as criteria for reaching the true VO2max (29). For the 
CAD-patients a plateau of the VO2-curve was not uniformly seen at pre-test, even if 
the effort was close to exhaustion (RER = 1.09). The determination VO2peak was thus 
used in paper I but the term VO2max is uniformly used throughout this thesis to 
simplify the expression of maximal aerobic capacity. Also, to secure that learning to 
walk properly on the treadmill was not influencing the VO2max-measurements, an 
instructor blinded for the values of the initial test carried out a second VO2max-test
within one week on 10 of the CAD-patients. The coefficient of variation between the 
two measurements was only 0.5%, certifying that a true VO2max was measured 
initially (unpublished results).
Healthy individuals (study II and III) 
An individually adjusted treadmill running ramp protocol was used for measuring 
VO2max in healthy individuals using MetaMax II. After a 10 minute warm-up period at 
a speed (7-10 km  h-1) and an inclination (0-5%) adjusted to the subject’s fitness 
level, the inclination was increased to 10%. The speed was thereafter increased by 1 
km  h-1 every minute until exhaustion. To ensure that a true VO2max was reached, two 
criteria had to be met: A levelling-off of VO2 despite an increase of exercise power 
and a respiratory exchange ratio above 1.05.
Brachial artery FMD 
Method used in study II-IV 
Endothelium-dependent and independent dilatation was studied according to the 
method originally described by Celermajer et al. (102). The guideline for 
determination of FMD described by Corretti et al. (110) was followed. Endothelial 
function of the artery was measured using high resolution vascular ultrasound (14 
MHz linear-phased array probe, Vivid 7 system, GE Vingmed Ultrasound AS, Horten, 
Norway). The measurements were performed on the left brachial artery above the 
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antecubital fossa. After a ten minutes rest in supine position in a quiet, air-
conditioned room with a stable temperature of 22 ± 1qC, blood flow (with an 
insonation angle at 60°) and internal diameter of the brachial artery was assessed. 
Thereafter we inflated a pneumatic cuff (Hokanson SC10) on the upper arm to 250 
mmHg for five minutes and deflated it to create an ischemia-induced hyperaemic 
elevated blood flow. Data were recorded 10 seconds after cuff-release to measure 
peak blood flow and thereafter every 30 seconds for five minutes observing the artery 
diameter. The subjects then rested until the baseline diameter was restored (5-10 
minutes) before endothelium-independent response was studied. After sublingual 
administration of 500 µg glycerol trinitrate (GTN) the diameter of the artery was 
measured for four minutes. All ultrasound images were analyzed in random order, 
using EchoPAC (GE Vingmed Ultrasound AS, Horten, Norway) by one person not 
knowing the group allocation of the subjects. To avoid confounding effects of arterial 
compliance and cyclic changes in arterial dimension all measurements were obtained 
at the peak of the R-wave in the ECG. Diameters were measured from intima to 
intima using callipers with a 0.1 mm resolution. The mean of three (study II and IV) 
and five (study III) diameter measurements and flow measurements were used in the 
calculation of FMD, GTN and flow-responses. Maximal dilatation was observed one 
minute after cuff release in all studies and those data are presented in the results.
Methodological considerations  
We applied the FMD test of the brachial artery induced by reactive hyperaemia 
because this test may represent the prime standard for clinical research on conduit 
artery endothelial biology (105). The test is widely used, but many between-
laboratory differences in methodology have made between-study comparisons 
challenging (136,166). Therefore, some methodological considerations regarding the 
execution must be made. 
Cuff placement 
A cuff placement proximal to the measure site was chosen to produce a larger 
brachial artery dilatory response (167), which is favourable to detect any further 
dilatation after the expected large post-exercise resting arterial diameter resulting 
from an acute exercise bout. In addition, studies showing relation between FMD in 
coronary and brachial arteries in suspected coronary artery disease have used both 
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proximal and distal cuff placement to create a hyperaemic stimulus (113,114). The 
studies in this thesis were conducted in 2004, and the guidelines by Corretti et al. 
(110) published in 2002 were followed. The Corretti report presented state-of-the-art 
information in the area of reactive hyperaemia mediated FMD of the brachial artery 
assessed by ultrasound, but there was no consensus whether upper arm or forearm 
occlusion provided the most accurate information.
NO-dependency
Two “updates” of the guidelines presented in 2005 (99,108) stressed the importance 
of distal occlusion when the intention is to measure NO-mediated endothelial 
vasodilatation. At present, the consensus seem to be that dilatation is blocked by the 
NO inhibitors L-NMMA or L-NAME when the occlusion is of five minutes duration, 
performed with no handgrip exercise and the cuff is placed distal to the measure site 
(141,168-171).
Significance of cuff placement 
An important methodological aspect is therefore that when the mechanistic isolation 
of NO is desirable, distal occlusion should be used, but when other clinical or basic 
research perspective is desirable, proximal occlusion should not be refused (99). A 
study by Silva et al. (172) concluded that the cuff location during FMD measurements 
does not play an important role in the accuracy of the test to differentiate patients 
with and without CVD risk factors. It should also be stressed that the extent of studies 
finding a predictive value of brachial artery FMD and the occurrence of mortality and 
cardiovascular events have used both proximal (123,126-128,130,132,173) and 
distal cuff placement (129,131,133,174). This indicates that mechanisms 
independent of NO also contribute (e.g. Prostacyclin, EDHF, potassium, and 
sympathetic activation) to cardiovascular health and their relative contribution should 
be clarified (175). Both upper and lower arm cuff placements should therefore be 
used in future research to detect in what extent NO-mediated or non-NO-mediated 
mechanisms contribute to different treatments of cardiovascular diseases.  
Stimulus-response 
Arterial wall shear stress during peak hyperaemia has been found to be linearly 
related to the resulting diameter percent change from baseline (176). This makes a 
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challenge in study II and III where the size of the brachial artery differs between 
groups. Shear rate was used as a surrogate measure for vascular shear stress, and 
was calculated as blood flow velocity (cm  s-1) divided by diameter (cm) (99). The 
adjustment to shear rate area under curve was not used because there was no clear 
evidence as to which shear stimulus quantity normalisation would be presented until 
recently (177).
Repeatability
The reproducibility and repeatability of the method have been described previously 
(99,108) and the coefficient of variation of intraobserver baseline brachial diameter 
measurements in our laboratory is 2.9% (178). 
Anthropometrical considerations 
In study III, we compared highly trained athletes with untrained counterparts, and the 
athletes had significantly less body weight than untrained. When comparing people 
with different body weight in running, VO2max should be expressed relative to body 
weight raised to the power of 0.75 (179) because VO2 does not increase in direct 
proportion to body weight. Data are thus also presented as mL  kg-0.75  min-1. In 
addition, blood vessel diameter and FMD were also corrected and analysed relative 
to body surface area (BSA) (180).
Aerobic exercise training 
The high-intensity exercise was chosen to be aerobic interval exercise at 80-90% of 
VO2max because this training method has been employed by our research group in 
healthy individuals earlier, being effective in improving VO2max at a relative short time-
period (24,181). The moderate intensity exercise at 50-60% of VO2max was selected 
because it is typically used in training studies involving patients with CAD (64) or with 
the metabolic syndrome (78).
CAD-patient training (study I) 
All CAD-patient training consisted of uphill treadmill walking three times per week for 
ten weeks. The high intensity interval group carried out a 5 minutes warm-up period 
at an intensity corresponding to 50-60% of VO2max (65-75% of HRmax) (29,182) before 
walking four intervals of 4 minutes at 80-90% of VO2max (85-95% of HRmax). Between 
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the intervals 3 minutes walking at 50-60% of VO2max was conducted. The training 
session was terminated by a 3 minutes cool-down period at 50-60% of VO2max. This 
gave a total exercise time for the high intensity group of 33 minutes. To equalise the 
total work performed by the two groups the following calculation was used: the 
average VO2max for all subjects before training was 2.55 L  min-1. The high intensity 
group performed 4 x 4 minutes exercise at 2.29 L  min-1 (90% of VO2max) and 3 x 3 
minutes exercise at 1.53 L  min-1 (60% of VO2max). The total VO2-time relationship for 
the high intensity group was then divided by the intensity for the moderate intensity 
group (50.49/1.53 = 33 minutes). Finally the warm-up and cool-down exercise time 
for the high intensity group (5 + 3 minutes) at 1.53 L  min-1 was added to this value. 
The moderate intensity exercise training thus consisted of 41 minutes continuous 
exercise at an intensity of 50-60% of VO2max, representing the same total training 
load as the high intensity aerobic exercise group.  
Metabolic syndrome training (study IV) 
Both exercise-groups performed aerobic endurance training, walking/running uphill 
on a treadmill three times per week for 16 weeks. The high intensity interval group 
warmed-up for 10 minutes at 70% of HRmax before performing four 4 minutes 
intervals at 90-95% of HRmax, with 3 minutes active recovery at 70% of HRmax
between each interval, and a 5 minutes cool-down period, giving a total of 40 
minutes. To equalise training volume (i.e. spending the same amount of kcal each 
session) the moderate intensity exercise group had to perform 47 minutes at 70% of 
HRmax each exercise session (see above section for calculation). The control group 
followed advice from their family doctor. For assessment of the acute effects of 
exercise, the patients accomplished one session of their respectively training regime.
Adjustment and control of training 
All subjects exercised using a heart rate monitoring device during every training 
session to control their corresponding exercise heart rate relative to VO2max, and was 
encouraged by the instructor to exercise as close to the upper intensity border as 
possible. The speed and inclination of the treadmill were continually adjusted along 
as training adaptations occurred, to ensure that all training sessions were carried out 
at the desired heart rate throughout the training period. The BORG 6-20 scale (183) 
was used to measure the rate of perceived exertion after each training session.  
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Athlete and healthy individual acute exercise (study III) 
In study III, highly endurance trained men and their untrained counterparts 
accomplished one high-intensity aerobic exercise session. Subjects were not allowed 
to exercise for the last 48 hours before the study started. In addition, the athletes did 
not perform any hard bouts of exercise-training the last 96 hours prior to the 
experiment. Immediately after the initial FMD measurements, all subjects performed 
a treadmill exercise protocol at the same relative exercise intensity: After 15 minutes 
warm-up, running at 60-70 % of HRmax, subjects ran 5 x 5 minutes with the three last 
minutes of every bout above 90 % of HRmax. The two first minutes of the bout were 
used to gradually enter the training zone. Between each interval, subjects performed 
two minutes active recovery at an intensity corresponding to 60-70 % of HRmax.
30
SUMMARY OF RESULTS 
Paper I. High intensity aerobic interval exercise is superior to moderate 
intensity exercise for increasing aerobic capacity in patients with coronary 
artery disease. 
1. The 18% improvement of VO2max after aerobic interval training was 
significantly greater than the 8% improvement after moderate intensity 
exercise training. 
2. Aerobic interval training improved VO2max by 0.63% per training session 
attended, which was more than twice as high compared to the 0.29% 
improvement in the moderate intensity group. 
3. There were no detectable changes in resting blood pressure, resting heart 
rate, or body mass in neither group after the training period.
4. There were no cardiac events during the study.  
Paper II. Endothelial function in highly endurance-trained and sedentary, 
healthy young women.  
1. Despite a 50% difference in VO2max, there was no difference in brachial artery 
FMD between the sedentary and the trained group. 
2. The endurance-trained group showed a FMD of 14.8% compared to 16.4% in 
the untrained group. 
3. There was a trend towards larger absolute baseline arterial diameters in the 
trained group, and when adjusting for body surface area, the trained females 
showed a 9% larger baseline diameter than their sedentary counterparts. 
Paper III. Endothelial function in highly endurance-trained men: Effects of 
acute exercise. 
1. There were no differences in FMD between groups, neither expressed in 
absolute terms nor in percent, at any time-point, even when normalised for 
shear stress. 
2. Resting as well as maximal arterial diameter measured one minute after cuff-
release were 10-15% larger in the trained group both before exercise, one 
hour, 24 hours and 48 hours after the exercise session. 
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3. Nitric oxide bioactivity was elevated by 93% in the trained group and by 63% 
in the untrained group one hour after the training, and decreased to baseline 
level after 24 hours in the sedentary group, but stayed elevated by 80% above 
baseline after 24 hours and by 93% after 48 hours in the trained group. 
4. The circulating antioxidant level increased by 7% and 10% one hour post-
exercise in the untrained- and trained group respectively. The antioxidant 
status was back to baseline 24 hours after exercise in both groups and 
decreased to a level 5% below baseline in the trained group after 48 hours. 
Paper IV. Aerobic interval training vs. continuous moderate exercise as a 
treatment for the metabolic syndrome - “A Pilot Study”.  
1. Aerobic interval training and continuous moderate exercise training increased 
VO2max by 35% and 16%, respectively after 16 weeks of exercise. 
2. Aerobic interval training and continuous moderate exercise improved FMD by 
9% and 5%, respectively.
3. Both groups exhibited a slight reduction (3-4%) in body weight despite no diet 
alterations during the intervention period. 
4. A decreased systolic and diastolic blood pressures was seen in both groups 
(~10 mmHg, and ~6 mmHg, respectively).
5. At the end of the training period, 46% in the aerobic interval training group and 
37% in the continuous moderate exercise group were no longer diagnosed 
with the metabolic syndrome, as opposed to the control group in which the 
syndrome persisted in all subjects. 
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DISCUSSION
The results of the present thesis demonstrate that high-intensity aerobic exercise is 
superior to moderate intensity exercise for increasing aerobic capacity in both 
patients with CAD and the metabolic syndrome. Endurance-trained athletes showed 
similar FMD but larger arterial diameter than untrained, and possessed an increased 
bioavailability of NO and elevated antioxidant status to acute high-intensity exercise. 
Furthermore, aerobic exercise, at high intensity in particular, seems to be an 
important factor for improving the risk factors of the metabolic syndrome, including 
endothelial dysfunction. Because of the equalisation of training-load this solely point 
out high exercise intensity as a key factor for increasing VO2max and decreasing 
cardiovascular risk factors among these patients.  
Aerobic exercise in CAD-patients (study I) 
The main goal of study I was to evaluate the effect of exercise in CAD-patients when 
intensity is the only parameter being manipulated. The improvement of 18% in the 
high intensity group compared to 8% in the moderate intensity group reflects the 
importance of exercise intensity for increasing VO2max. This may have important 
impact not only on functional capacity but also on survival prospects as improved 
aerobic capacity has been shown to reduce mortality (47-53). 
Effects of exercise intensity for improving VO2max
While our study I is one of very few where CAD-patients were performing aerobic 
interval exercise at 80-90% of VO2max, continuous exercise at 50-60% of VO2max is 
more frequently used (64). Two earlier studies involving CAD-patients have 
employed aerobic interval exercise with elements of the same high intensity as in the 
present study, showing the largest improvement of VO2max to date (43,184). The 
improvement in VO2max of 37-42% found in these studies are however difficult to 
compare to our study because of the longer training period of 12 months. Jensen et 
al. (185) had two groups of CAD-patients training for 12 months, involving high-
intensity exercise within the range of the present study. One hundred and eighty-six 
subjects with a documented CAD event within the previous 24 months were 
randomised to 45 minutes of walking or jogging at either 85% or 50% of VO2max. The 
results showed that VO2max in the high intensity group increased by 13% which was 
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significantly higher compared to the 9% increase in the lower intensity group. Adachi 
et al. (186) compared 29 patients with previous myocardial infarction randomised to 
either walking exercise at 70% of VO2max or at 55% of VO2max over eight weeks. 
VO2max increased by 17% in the high intensity group and 9% in the moderate 
intensity group. Contrary to these studies, Blumenthal et al. (187) did not detect 
differences between moderate intensity (75% of VO2max) and low intensity exercise 
(45% of VO2max) after 12 weeks of training among 45 patients with myocardial 
infarction. VO2max increased by 11% within the high intensity group and 14% in the 
low intensity group, but the differences were not statistically significant. Same 
conclusions was made by Warburton et al. (188) who found that high-intensity 
interval training resulted in similar improvements in aerobic fitness in comparison to 
traditional continuous aerobic exercise training in CAD-patients. In sum, however, 
these findings support our study with regard to the fact that higher intensity exercise 
being more suitable for increasing VO2max compared to lower intensity exercise in 
CAD-patients.
Equalisation of exercise 
Our results are thus in accordance with previous work indicating that high-intensity 
exercise is more suitable for increasing VO2max compared to moderate or low 
intensity exercise (43,184-187). But, in each of the former studies the two groups 
used the same exercise duration and the higher intensity groups therefore performed 
a greater total amount of training. It is therefore uncertain whether intensity or total 
amount of work was the most determining for the increase in VO2max. The 
equalisation of exercise load between the groups in study I was emphasised to 
control if intensity is a capital factor for increasing VO2max. In addition, all subjects 
exercised with heart rate monitoring device and the load of the treadmill could 
therefore progressively be adjusted to keep the relative exercise intensity constant as 
training adaptations occurred throughout the study. More recent work from our 
research group have confirmed the results from study I in healthy individuals (189), 
and in patients with chronic heart failure (40), intermittent claudication (190) and 
metabolic syndrome (study IV).
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Absolute vs. relative improvement of VO2max
The initial VO2max of the patients in our study was 32.0 mL  kg-1  min-1, which is 
higher compared to the other studies evaluating exercise intensity in CAD-patients 
(18.7-25.3 mL  kg-1  min-1) (185-187). Thus, the 18% improvement of VO2max in the 
high intensity group is therefore considerable when calculating percentage 
improvement from such a higher baseline value. In fact, VO2peak increased by 0.63% 
and 0.29% per training session accomplished for the high and moderate exercise 
group, respectively.
Mechanisms of improved VO2max
An echocardiographic analysis of the patients in study I, presented by Amundsen et 
al. in a separate study (39), revealed that left ventricular early diastolic myocardial 
relaxation rate improved only in the high intensity-exercise group indicating the 
significance of high intensity for elevation of diastolic function and VO2max. This 
coincides with previous studies where diastolic function seems to be more closely 
related to VO2max than systolic function (191). A close relationship has previously 
been found between early diastolic function, stroke volume and VO2max in patients 
with hypertrophic cardiomyopathy (192). Although not measured it is reasonable to 
believe that adaptations also appeared in the skeletal muscles due to improvements 
in oxidative characteristics as well as in endothelial function of the conduit arteries 
(29,138). Other possible mechanisms of adaptations due to different exercise 
intensities were therefore further investigated in study II-IV. 
Endothelial function in trained vs. sedentary women (study II) 
The results from study II suggest that long-term endurance training does not improve 
FMD of the brachial artery above normal levels in young, healthy women. Despite a 
50% difference in VO2max between the two groups, there was no difference in FMD 
between highly trained and sedentary individuals.
FMD in healthy, young individuals 
Our results correspond with other cross-sectional comparisons of endothelial function 
between active and sedentary young subjects. Both longitudinal and cross-sectional 
studies indicate that exercise training has relatively little or no impact when 
endothelial function is well preserved at baseline (138,140) while aerobic exercise 
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interventions have shown improvements in endothelial function when it is reduced by 
age (193), heart failure (194), CAD (148), hypertension (152) or type 2 diabetes 
(151). DeSouza et al. (193) reported no differences in forearm vascular responses to 
acetylcholine between trained and sedentary men aged ~27. Similarly, Taddei et al. 
(163) reported equal forearm blood flow modifications induced by intrabrachial 
acetylcholine in male athletes and sedentary subjects aged ~27, and concluded that 
endothelial function is well preserved and cannot be affected by potentially beneficial 
intervention such as aerobic exercise. Kingwell et al. (195) found no change in 
endothelial dilatation in the forearm after four weeks of cycling in 13 sedentary, ~24 
year old males. Also, a study by Maiorana et al. (151) found that eight weeks of 
exercise training did not alter forearm acetylcholine response in middle-aged healthy, 
sedentary subjects. Contrary, Clarkson et al. (196) found that a 10 week aerobic and 
anaerobic exercise program improved FMD from 2.2% to 3.9% in male military 
recruits. This study included smokers, who most likely influenced the results, as 
smoking is associated with impaired FMD (120). The sum of the discussed studies, 
together with our results, suggest that aerobic exercise improves endothelial function 
only when it is impaired at baseline, and that the dilatory response is unaffected by 
exercise capacity in healthy, young individuals. The phenomenon of improved FMD 
caused by long-term aerobic training thus seems to be valid mostly when 
investigations include subjects who possess cardiovascular risk factors or 
established cardiovascular disease.  
Adjustment for diameter size 
The highly-trained females showed a significantly 9% larger resting brachial arterial 
diameter when adjusting for BSA. This corresponds to former studies where 
specifically trained athletes possessed larger conductive arteries compared to 
untrained counterparts (197,198). One may then speculate if a larger brachial arterial 
diameter is a stronger indicator of improved endothelial function rather than FMD 
when comparing highly trained and sedentary young subjects. We found neither any 
difference in FMD between trained and untrained females when adjusting for BSA. 
Thus, the results of study II indicate FMD to be similar in highly-trained and sedentary 
females. This suggests that endothelial function is being well preserved in untrained, 
though healthy, young women. 
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Effects of acute exercise on FMD in healthy individuals (study III) 
The main findings of study III was that highly endurance-trained athletes had larger 
arterial diameter but similar FMD compared to untrained controls, i.e. indicating a 
long-term exercise induced difference in vessel size. Also, when normalizing for peak 
hyperaemic shear rate we could not observe any differences in FMD between 
groups. Furthermore, we observed increased bioavailability of NO and elevated 
antioxidant status to acute exercise, which was highly dependent upon the time 
elapsed after exercise. 
FMD before acute exercise 
There were no significant differences in FMD between the groups at baseline. This 
suggests that the FMD, which is believed to be mediated mainly by NO, is well 
preserved in sedentary young, healthy individuals and not a limiting step for 
delivering large amounts of blood to the exercising musculature as is the case during 
strenuous exercise. This indicate that the differences in arterial diameter and not in 
FMD may be a more important mechanism to accommodate the substantial higher 
cardiac output that has to be transported by the blood vessels to the exercising 
muscles in individuals with a VO2max of 75.9 mL  kg-1  min-1 observed in the athletes, 
compared to a VO2max of 47.7 mL  kg-1  min-1 in the untrained individuals.  
FMD after acute exercise 
FMD measured one hour after the training session was significantly reduced 
compared to FMD at baseline among the highly endurance-trained athletes, whilst 
baseline values were observed 24 and 48 hours post-exercise. One may speculate 
whether this reflects impaired endothelial function one hour after the training session 
and normalisation within 24 hours. However, we observed increased bioavailability of 
NO and improved antioxidant status in blood samples taken one hour post-exercise, 
suggesting that other mechanisms than NO and antioxidant levels were responsible 
for the transient decay in FMD observed in the endurance athletes. Therefore, the 
large resting artery diameter observed among the athletes one hour post-exercise 
combined with high levels of nitric oxide in plasma, may have dilated the vessel close 
to maximum, reducing the shear stress imposed by reactive hyperaemia and thus 
reducing FMD. 
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Adjustment for shear rate 
Peak blood flow after cuff release was greater in athletes compared to the untrained 
subjects. Despite the lower absolute peak blood flow, untrained subjects showed 
higher peak shear rate at all time points compared to the athletes. Silber et al. (176) 
demonstrated that arterial FMD is linearly proportional to peak hyperaemic shear 
stress in normal subjects, i.e. the endothelial response is linearly proportional to the 
stimulus. In line with this, we observed a significant inverse correlation between FMD 
and resting arterial diameter at baseline (r = -0.51) and thus reproduced earlier 
findings that larger arteries will dilate less compared to smaller arteries (102). The
greater FMD-response in small arteries is suggested to be mediated, at least 
partially, by a greater hyperaemic shear stress. It has been demonstrated that the 
hyperaemic shear stimulus for FMD is greater in small arteries due to the 
dependence of postischemic systolic flow on radius squared. Therefore, greater FMD 
in smaller arteries does not reflect better conduit artery endothelial function (199). 
Thus, it might be that FMD in the untrained controls, with smaller artery diameter 
compared to the athletes, was overestimated. However, even when we normalized 
for shear rate we could not observe any differences in FMD between the groups. The 
reason for this may be either that the present test of endothelial function is not 
sensitive enough to detect differences between a normal and a supra-normal 
endothelial function, or that a supra-normal endothelial function is not necessary to 
deliver large amounts of blood to exercising muscles. However, due to the significant 
larger diameter of the brachial artery and a normal FMD the athletes have a 
substantial higher capacity to transport large amounts of blood during strenuous 
exercise compared to the untrained individuals, and as such they have improved 
“functional” arterial function.
Possible vascular harmful effects of high-intensity exercise 
Study III further detected decreased antioxidant status 48 hours after exercise. It has 
previously been suggested that high-intensity exercise may induce oxidative stress 
that impairs the endothelial function (164). Bergholm et al. (162) found that aerobic 
training (70-80% of VO2max) decreased the circulating antioxidant level and impaired 
the endothelial function in forearm vessels in healthy males after four weeks running 
training. Their vascular measurements were performed at least 36 hours after the last 
training session. Accordingly, their data correspond to ours, but in contrast, we found 
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unchanged FMD and increased NO in blood at both 24 and 48 hours after exercise. 
The reason for this discrepancy remains unknown but could be related to the much 
higher level of aerobic capacity in the athletes in the present study yielding other 
protective endothelial characteristics.
Significance of increased NO-production 
Interestingly, despite the decreased level of antioxidant capacity (i.e. increased level 
of reactive oxygen species) 48 hours post acute exercise in athletes, the 
bioavailability of NO remained 93% above baseline values. This suggests that the 
transient decrease in antioxidant status in athletes was physiologically insignificant. 
The increased production of NO may have been responsible for this. Recently, 
Hambrecht et al. (200) linked the effect of regular exercise training to an increase in 
eNOS protein expression and activation of eNOS enzyme activity via Akt-dependent 
phosphorylation at the serine residue 1177 (Ser1177). Protein expression of eNOS as 
well as  phosphorylation at  Ser1177 were found to be two-fold and four-fold higher in 
the left internal mammary artery after four weeks of exercise training in patients with 
stable coronary artery disease compared to sedentary counterparts. The Ser1177
residue seems to be a target for shear stress sensors, and its phosphorylation leads 
to a rise in the enzyme activity of eNOS and enhanced NO production (201). Thus, 
exercise seems to have a dual positive effect by both increased protein expression of 
eNOS, which may take a few hours (201,202) and it enhances the phosphorylation of 
eNOS at Ser1177 minutes after increased shear stress, thereby leading to increased 
vascular NO-production. Interestingly, the shear stress-induced phosphorylation of 
eNOS is maintained (203), whereas the agonist-mediated Ser1177 phosphorylation is 
only transient (204). Hambrecht et al. (200) showed that exercise training has a larger 
impact upon phosphorylation of eNOS at Ser1177 than on the expression of the eNOS 
protein itself. Sustained phosphorylation of eNOS could thus explain sustained 
increased NO production in athletes up to at least 48 hours post-exercise. 
Furthermore, our study showed a sustained increased level of NO for at least 48 
hours that occurred in conjunction with reduced levels of blood glucose and low 
density lipoproteins, both known to be inversely related to the NO-production.   
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Significance of blood lipids on FMD 
Low-density lipoprotein cholesterol and triglycerides were significantly higher in the 
sedentary group while the HDL cholesterol was significantly higher in the trained 
group. All mean values were still in the normal range. Also in study II we found no 
difference in FMD between highly trained and sedentary, young women. The 
endurance-trained women had a higher HDL-cholesterol but similar LDL-cholesterol 
and triglyceride-values compared to the sedentary group. Similar, Taddei et al. (163) 
reported the same endothelial function despite higher LDL- and lower HDL-
cholesterol in a sedentary group compared to athletes (mean age ~27). This 
suggests that differences between lipid levels that are still within the normal range do 
not affect the endothelial function, although it may influence the NO-production in 
young, healthy subjects on a short term basis. These findings contrast those of 
Steinberg et al. (205) who found that elevated total- and LDL-cholesterol levels, even 
in the high normal range, may be associated with endothelial dysfunction. The mean 
age in Steinberg’s study was ~32 years compared to ~24 years in our study. Thus, 
the endothelial dysfunction may be a long-term effect that is not apparent in early 
adulthood in non-obese individuals. Kingwell et al. (161) showed improved 
endothelial function in ~35 year old endurance athletes compared with age-matched 
sedentary men. A covariance analysis suggested that a lower total cholesterol in the 
trained group contributed to the enhanced vasodilator response. This supports the 
hypothesis that total cholesterol level influences the endothelial function more with 
increasing age. Finally, De Souza et al. (193) reported similar endothelial function 
and blood lipid profiles in healthy sedentary compared to trained young men.
Brachial artery diameter size 
Athletes had larger arteries compared to sedentary counterparts, and a large resting 
brachial artery diameter has been shown to be an independent predictor of CVD 
events (131,206). However, a larger arterial diameter with preserved function in 
athletes may be an analogue to physiological hypertrophy of the athlete’s heart with 
improved function vs. the pathological hypertrophy (i.e. observed in patients with 
heart failure) with impaired function. Increased arterial diameter on the basis of an 
exaggerated production of nitric oxide in athletes may suggest improved structural 
function. The mechanisms responsible for mediating vascular structural enlargement 
are not fully understood but there are indications that NO plays an important part, and 
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that shear stress is the trigging factor (207). Acute exercise may up-regulate the 
eNOS expression to buffer increased shear stress. Following long-term exercise 
training, NO-mediated structural adaptation may occur, resulting in chronic increase 
in vessel calibre which structurally normalises the shear stress (140). It thus seems 
that a larger brachial arterial diameter may be a stronger indicator of improved 
endothelial function rather than FMD, when comparing highly-trained and sedentary 
young subjects.
The results of study II and III suggest that endothelial function is well preserved in 
young, healthy males, and that a high aerobic training status due to long term aerobic 
training does not improve the dilatation capacity any further. However, the 
transporting capacity of blood is larger in athletes due to a larger artery diameter. In 
addition, one strenuous high-intensity exercise session increased bioavailability of 
NO and elevated antioxidant status and did not seem to impair the endothelial 
function. Large arteries in athletes are most likely linked to good function whereas 
large arteries in untrained subjects and patients are linked to poor function. Thus, 
“the athlete’s artery” may be an analogue to the “athlete’s heart” with good function 
vs. the pathological hypertrophied heart with poor function.
Role of exercise in reversing the metabolic syndrome (study IV) 
The results from study IV indicate that aerobic exercise, and high-intensity exercise in 
particular, is an important factor for improving aerobic capacity and reversing the risk 
factors of the metabolic syndrome including endothelial dysfunction, fasting glucose, 
insulin-action and lipogenesis. The closely supervised training regimens and the 
comparable training volumes between the two exercise groups are strong features of 
the study and demonstrate the importance of exercise training in reducing the risks of 
metabolic syndrome. Exercise training, especially at high-intensity, appears to be 
highly beneficial in preventing the metabolic syndrome relative to any other currently 
known interventions. These findings may have important implications for exercise 
training in rehabilitation programs. While larger studies using exercise with high 
relative intensity to treat patients with the metabolic syndrome are needed to advance 
our conclusions, we propose that high-intensity exercise training programs may yield 
more favourable results than those with low-to-moderate intensities. 
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Aerobic capacity 
Of all established risk factors, low aerobic exercise capacity appears to be the 
strongest predictor of mortality (47-52). Study IV demonstrates that high-intensity 
exercise increased VO2max to a higher degree than moderate-intensity exercise in 
patients with the metabolic syndrome. Central oxygen delivery and peripheral oxygen 
utilisation, probably contributed to the training-induced changes in VO2max (40). 
Accordingly, high-intensity exercise increased maximal stroke volume (indicated by 
improved O2 pulse), as well as Ca2+ cycling and mitochondrial capacity in skeletal 
muscle (as assessed by improved SERCA-capacity and PGC-1D levels in m. vastus 
lateralis) to a larger extent than moderate exercise.
Aerobic capacity and weight loss 
The similar weight loss between exercise intensities, but a larger total reduction of 
the cardiovascular risk factors that constitute the metabolic syndrome after high- 
intensity exercise, are in line with epidemiological observations suggesting that it may 
be more important to become fit than to loose weight per se (208,209). Moreover, 
although obesity and aerobic capacity are strong and independent prognostics 
markers for cardiovascular mortality, the link between aerobic capacity and mortality 
seems to be stronger (208,209). This suggests that it is more beneficial to target 
aerobic capacity before weight loss, although improvement of both risk factors 
probably would be ideal. However, larger studies are needed to address this issue. 
Applicability of high-intensity exercise 
Study IV suggests that exercise in general and high-intensity exercise in particular is 
partly or fully able to reverse the metabolic syndrome, suggesting that this may be a 
promising treatment strategy. It is important to create effective and affordable 
prevention and treatment strategies to improve wide-scale health outcome and slow 
down the current epidemic of overweight, to prevent the epidemic of metabolic 
syndrome from reaching global proportions (210). However, despite the results 
presented here, the interval protocol may not be readily acceptable to the general 
population of patients with the metabolic syndrome. On the other hand, an exercise 
intensity of 90% of HRmax corresponds to ~20 beats/min below maximum. This 
implies that the patients would have tolerated higher exercise intensities (but with 
shorter durations), and that most patients walk “up-hill” on the treadmill to avoid 
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running and thereby reduce the risk of musculoskeletal injuries caused by the 
mechanical load at high running speeds. To obtain the intended exercise intensity 
during home-based interval training, we normally instruct patients to exercise such 
that they are breathing heavily and talking becomes uncomfortable during each 
interval, without developing severe leg stiffness, and that it is an absolute 
requirement that they should be able to perform four-minute intervals in succession. 
These instructions were satisfactory in old patients with post-infarction heart failure 
(40) and may therefore also be feasible for patients with the metabolic syndrome. 
These observations suggest that it may be possible to instruct patients to perform 
such training without monitoring heart rate.  
Intensity-mediated differences in endothelial function 
High-intensity training improved FMD more than continuous exercise among the 
metabolic syndrome patients. In keeping with the notion that exercise-induced 
improvement in vessel relaxation is mainly mediated by NO (211) we observed no 
group-differences in endothelium-independent relaxation in the brachial artery after 
administrating nitroglycerine sublingually. This suggests that the effect of high 
intensity is mediated by improved NO-bioavailability. Consistent with this hypothesis, 
high intensity, but not moderate intensity, normalised the level of blood glucose, 
insulin sensitivity and the amount of oxidized LDL-cholesterol, which directly 
influence NO bioavailability (93). The reason for the difference in FMD between 
groups is not fully understood, but it seems reasonable to suggest that the low- and 
high-intensity exercise programs differently affect shear stress on the walls of blood 
vessels during exercise training, and that this yields differences in molecular 
responses. Studies performed in humans indicate agreement that NO contributes to 
resting and post-exercise blood flows, although its contribution during exercise 
remains controversial (140,212,213). A definitive support for involvement of any 
specific vasodilator substance is indeed lacking, but numerous vasodilators such as 
adenosine, ATP, potassium, oxygen, lactate, H+, NO, prostacyclin, and EDHF have 
been suggested to contribute to the local vasodilatation during the exercise (214). 
One explanation of exercise-induced improvements of FMD might be a release of 
one or more of these vasodilator agents from active muscle beds and their 
subsequent circulation to inactive regions, e.g. the brachial artery. 
43
Possible systemic endothelial effects during exercise 
Another possible explanation of the improved brachial artery FMD may be through 
direct stimulation. Even if increased blood flow during exercise is concerned as a 
muscle task-specific phenomenon, Tanaka et al. (215) found that there was an 
approximately fourfold increase in blood flow also in the brachial artery from rest to 
90% of peak work rate during graded bicycle leg-exercise. Also Green et al. (211) 
have demonstrated that exercise exerts a generalised effect on the vasculature by 
increasing NO activity in vascular beds other than those that perfuse the actively 
working muscles. Their results showed that lower limb exercise actually was a more 
potent stimulus to forearm shear stress and NO production than localised handgrip 
exercise, because of an oscillatory pattern of antegrade/retrograde flow in the arm 
during whole body exercise. In addition to an increased total flow, blood actually flow 
backwards towards the heart during diastole (216). Such exercise seems to produce 
both metabolic and haemodynamic stimuli to active and inactive vessel hyperaemia 
and this flow-pattern may produce a larger shear stress-mediated endothelial NO 
production than a pulsatile, albeit larger and unidirectional, antegrade flow stimulus 
(217). This mechanism could therefore, together with reducing CVD risk factors, 
explain the training-induced improvements in endothelial function in study IV, where 
FMD was measured in the brachial artery after exercising the legs. This implies that 
endothelial dysfunction may be systemically improved as soon as a critical muscle 
mass is trained at a level sufficient to increase blood pressure amplitude and shear 
stress. It therefore indicates the importance of high-intensity aerobic exercise as a 
mediator of a sufficient systemic haemodynamic/shear stimulus to induce global 
adaptation. 
Possible systemic endothelial effects after exercise 
Superior FMD due to high-intensity exercise may also have been mediated by 
differences in post-exercise shear stress. A recent study by Padilla et al. (218) 
demonstrated that walking at high intensity elicited the greatest magnitude of brachial 
artery shear stress during three hours post exercise measurements, compared to 
moderate and low intensity. The findings demonstrate that the brachial artery 
continues to be exposed to increases in shear stress during the recovery from 
walking exercise and that improvement of endothelial function previously observed in 
training studies may not only be due to the elevated shear stress during exercise but, 
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also to the alteration during the recovery (218). In view of this study, it is logical to 
anticipate that our patients training at high intensity would experience the greatest 
enhancement in brachial artery endothelial function because shear stress is highest 
in this group also during the hours after exercise. It is however important to keep in 
mind that improvements in the peripheral blood vessels in our study could also have 
been mediated through alterations in the sympathetic nervous system or other 
mechanisms not measured. 
Blood pressure 
Moderate- and high-intensity exercise reduced systolic and diastolic blood pressure 
by ~10 and 6 mmHg, respectively. Based on a meta-analysis of one million adults, a 
blood pressure lowering of this magnitude would in the long term be associated with 
about 40% and 30% decreases in the risks of premature deaths due to stroke and 
ischemic heart disease, respectively (219). 
Blood parameters
Furthermore, metabolic syndrome patients exercising at high intensity improved their 
insulin sensitivity, ȕ-cell function and glucose level more than the group exercising at 
moderate intensity. All together, study IV suggest that both exercise programs 
decreased body weight, but high-intensity exercise was particularly beneficial for 
decreasing fatty acid transport into the adipose tissue and promoting the suppressive 
effect of insulin on lipogenesis in this tissue. The mechanism for improved insulin 
action in muscle by high-intensity exercise is not clear. However, exercise is 
generally known to promote insulin action in muscle by decreasing the intracellular 
accumulation of triglycerides and promoting fatty acid oxidation (220). Consistently, 
high-intensity exercise increased mitochondrial biogenesis in skeletal muscle, which 
is in agreement with recent reports (221,222).
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CONCLUSIONS
The findings of the present thesis demonstrate that high-intensity exercise seems to 
be superior to moderate intensity for improving aerobic capacity and reduce the risk 
factors associated with cardiovascular disease, including endothelial dysfunction. The 
thesis may therefore bring new thoughts into the area of cardiovascular rehabilitation, 
with respect to the usefulness of high-intensity aerobic exercise for improving 
cardiovascular health. As improved VO2max is found to be a major determinant of 
increasing functional capacity and survival, this type of exercise may be employed to 
optimise the exercise component of both primary and secondary prevention in the 
future.
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ABSTRACT
Exercise training reverses endothelial dysfunction, but the
effect in young, healthy subjects is less clear. We determined
the inﬂuence of maximal oxygen uptake ( _Vo2max) and a single
bout of high-intensity exercise on ﬂow-mediated dilatation
(FMD), brachial artery diameter, peak blood ﬂow, nitric oxide
(NO) bioavailability, and antioxidant status in highly endurance-
trained men and their sedentary counterparts. Ten men athletes
(mean 6 SEM age 23.5 6 0.9 years, height 182.6 6 2.4 cm,
weight 72.5 6 2.4 kg, _Vo2max 75.9 6 0.8 mLkg21min21)
and seven healthy controls (age 25.4 6 1.2 years, height
183.9 6 3.74 cm, weight 92.8 6 3.9 kg, _Vo2max 47.7 6
1.7 mLkg21min21) took part in the study. FMD, brachial artery
diameter, and peak blood ﬂow were measured using echo-
Doppler before, 1 hour, 24 hours, and 48 hours after a single
bout of interval running for 5 3 5 minutes at 90% of maximal
heart rate. NO bioavailability and antioxidant status in blood
were measured at all time points. Maximal arterial diameter and
peak ﬂow were 10–15% (P , 0.02) and 28–35% (P , 0.02)
larger, respectively, in athletes vs. controls at all time points, and
similar FMD were observed, apart from a transient decay of
FMD in athletes 1 hour post exercise. NO bioavailability
increased signiﬁcantly after exercise in both groups and
decreased to baseline levels after 24 hours in controls but
remained increased 80% and 93% above baseline 24 and 48
hours post exercise in athletes. Antioxidant status was equal in
the two groups at baseline and increased by approximately
10% 1 hour post exercise, an effect that lasted for 24 hours.
Athletes had larger arterial diameter but similar FMD as
untrained subjects, i.e., athletes had larger capacity for blood
transport compared with their untrained counterparts. The
observed FMD, bioavailability of NO, and antioxidant status in
blood were highly dependent on the time elapsed after the
exercise session.
KEY WORDS ﬂow-mediated dilatation, oxygen uptake, aerobic
exercise, athletes
INTRODUCTION
E
ndothelial dysfunction plays an initial role in the
pathogenesis of atherosclerosis (21), and impaired
endothelial function has been observed several
years before traditional markers of cardiovascular
disease (4). Aerobic exercise has previously been found to
improve endothelial function in patients with chronic heart
failure (16), coronary artery disease (12), hypertension (14),
and type 2 diabetes (18) and to prevent age-related endo-
thelial impairment (7). Although it is generally accepted that
regular exercise training augments the endothelial function in
individuals with impaired function, the effects in young,
healthy subjects are less clear. Previous studies conclude that
regular exercise may enhance, decrease, or have no effect on
endothelial function in healthy subjects (2,5,7). There is only
one study of endothelial function in well-trained women
athletes (19), with an average maximal oxygen uptake of
60 mLkg21min21, reporting larger arterial diameter but
similar endothelial-dependent vasodilatation in endurance
trained subjects vs. untrained controls. In addition, there are
several studies of endothelial function in moderately
endurance-trained men (2,7,27), but there are none in highly
endurance-trained men athletes. Furthermore, high-intensity
endurance training at 70–80% of maximal oxygen uptake has
been linked to decreased antioxidant capacity and reduced
endothelial function in moderately well-trained men (2), but
it is not known whether this is true for highly endurance-
trained men.
Thus, in the present study, we compared the inﬂuence of
high vs. normal aerobic capacity and a single bout of high-
intensity interval running on arterial diameter, peak blood
ﬂow, endothelium-dependent dilatation in the brachial artery,
bioavailability of nitric oxide, and antioxidant status in
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well-trained and sedentary healthy men. We hypothesized
that athletes would have larger artery diameter but similar
endothelial-dependent vasodilatation, and that one high-
intensity aerobic exercise session would not impair endothe-
lial function in either group.
METHODS
Experimental Approach to the Problem
To assess the inﬂuence of high vs. normal aerobic capacity and
the acute vascular effects of strenuous aerobic exercise,
endothelial function was assessed and venous blood samples
were taken at baseline, 1 hour, 24 hours, and 48 hours after
ﬁnishing a single bout of high-intensity interval training
(Figure 1). Maximal oxygen uptake ( _Vo2max) and maximal
heart rate (HRmax) were measured 1–2 weeks before the study.
Subjects
Ten highly endurance-trained men athletes (cross-country
skiers, orienteering runners, and biathlon skiers) all in the
national team in their respective sport and within the top
10 on a national basis, and seven healthy sedentary men
recruited from university students took part in the study.
Inclusion criteria were a _Vo2max value either .70 mL
kg21min21 for athletes or,55 mLkg21min21 and less than
1 hour of exercise training per week for controls. Exclusion
criteria were a history of hypertension or diabetes mellitus
and family history of premature cardiovascular disease.
No subjects were taking any form of medication. Subject
characteristics are presented in Table 1. The investigation
conforms to the principles outlined in the Helsinki
Declaration and was approved by the regional committee
for medical research ethics. All subjects who participated in
the study provided written, informed consent.
Training Protocol
To investigate the acute effects of high-intensity aerobic
exercise on endothelial function, we chose a high-intensity
interval running exercise. Subjects were not allowed to
exercise for 48 hours before the study started. In addition,
the athletes did not perform any hard bouts of exercise
training 96 hours before the experiment. Immediately after
the ﬁrst endothelial function test, all subjects performed
a treadmill exercise protocol at the same relative exercise
intensity. After a 15-minute warm-up, running at 60–70 % of
HRmax, subjects ran 5 3 5 minutes with the last 3 minutes of
every bout .90 % of HRmax. The ﬁrst 2 minutes of the bout
were used to gradually enter the training zone. Between each
interval, subjects performed 2 minutes’ active recovery at an
intensity corresponding to 60–70 % of HRmax.
Endothelial Function
Endothelium-dependent and -independent dilatation was
studied according to the method originally described by
Celermajer et al. (4). The guidelines for determination of
ﬂow-mediated dilatation (FMD) described by Corretti et al.
(6) were strictly followed. The reproducibility and re-
peatability of the method have been established previously
(25), and the coefﬁcient of repeatability (3) of baseline
brachial diameter measurements in our laboratory is 4%.
Endothelial function of the artery was measured using high-
resolution vascular ultrasound (14 MHz ultrasound-Doppler
probe, Vivid 7 system; GE Vingmed Ultrasound AS, Horten,
Norway). The measurements were performed on the brachial
artery approximately 4.5 cm above the antecubital fossa. All
measurements were performed in the morning after 12 hours’
fast. In addition, subjects were not allowed to use nicotine
and coffee or any other caffeine-containing beverages for
12 hours preceding testing. All subjects were given instruc-
tions not to take vitamins or eat fat-rich meals during the
study or to eat 4 hours before testing. After 10 minutes’ rest in
the supine position in a quiet, air-conditioned room with
a stable temperature of 22 6 1C, the internal diameter of
the brachial artery was assessed.We then inﬂated a pneumatic
cuff on the upper arm to 250 mm Hg for 5 minutes and
deﬂated it to create an ischemia-induced hyperemic elevated
blood ﬂow. Data were recorded 10 seconds after cuff release
to measure peak blood ﬂow and thereafter every 30 seconds
for 5 minutes, while observing the artery diameter. The
subjects then rested for 5 minutes until the baseline diameter
was restored. Thereafter, endothelium-independent dilata-
tion was measured by administrating 500 mg glycerol
trinitrate (GTN) sublingually. To avoid confounding effects
of arterial compliance and cyclic changes in arterial dimen-
sion, all measurements were obtained at the peak of the
R-wave in the electrocardiogram. All ultrasound images were
analyzed in random order using EchoPACtm (GE Vingmed
Ultrasound AS) by one person who did not know the group
allocation of the subjects. Diameters were measured from
intima to intima using calipers with a 0.1-mm resolution. The
mean of three diameter measurements and ﬂow measure-
ments was used in the calculation of FMD, GTN, and ﬂow
responses. Maximal dilatation was observed 1 minute after
cuff release in both groups; those data are presented in
Results. Shear rate was calculated as blood ﬂow velocity
(cms21) divided by diameter (cm) (20).
Exercise Testing
A Metamax portable system (Metamax II; Cortex, Leipzig,
Germany) was used for measuring _Vo2max. An individually
adjusted treadmill running ramp protocol was used. After
a 10-minute warm-up period at a speed (7–10 kmh21) and
Figure 1. Timeline of the experimental protocol indicating when ﬂow-
mediated dilatation was measured and when the exercise protocol was
performed.
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incline (0–5%) adjusted to the subject’s ﬁtness level, the
incline was increased by 10%. The speed was thereafter
increased by 1 kmh21 every minute until exhaustion. To
ensure that the maximal value was reached, two criteria had
to be met: 1) A leveling-off of _Vo2 despite an increase of
exercise power and 2) respiratory exchange ratio .1.05 (1).
Total Antioxidant Status Measurement
Total antioxidant status wasmeasured in serum samples using
the colorimetric Total Antioxidant Status assay (Randox).
The method is based on 2,2’Azino-di-3-ethybenzthiazoline-
sulfate (ABTS) incubation with metmyoglobin andH2O2 to
produce the radical cation ABTS+. This radical has a stable
blue-green color that is measured at the wavelength of 600 nm.
Antioxidants present in the added sample weaken the color
intensity in proportion to their concentration. The assay was
performed using an automated system and according to the
manufacturer’s instructions.
Total Nitric Oxide Assay
Quantitative determination of total nitrite (NO2
2) concentration
was performed using a commercially available total NO assay
(R&D Systems, Inc., Minneapolis, MN). The assay determined
total NO based on the enzymatic conversion of nitrate to nitrite
by nitrate reductase. The reaction is followed by a colorimetric
detection at 540 nm nitrite as an azo dye product of the Griess
reaction. Brieﬂy, frozen EDTA plasma was diluted twofold into
reaction buffer and ultraﬁltrated through a cutoff ﬁlter (Nano-
sep; Pall Life Sciences) to eliminate proteins. All samples were
analyzed in duplicate, and the assay was performed according
to the manufacturer’s protocol.
Statistical Analyses
All values are expressed as means6 SEM. A non-parametric
test (Wilcoxon’s signed ranks test) was used to make com-
parisons within groups. Between-group differences were
calculated using the Mann-Whitney U-test. To test whether
FMD might be related to arterial diameter and _Vo2max,
Spearman’s correlation coefﬁcient was used. Statistical sig-
niﬁcance was deﬁned as a two-tailed P # 0.05. A pilot study
revealed that, for a given effect size (baseline arterial mean 4.0
vs. 3.5 mm), standard deviation 0.3 mm, sample sizes of 7
in each group, and a 0.05 (two-tailed), power was 0.816.
We therefore chose to include 7–10 people in each group.
RESULTS
The trained group had 59% higher _Vo2max, 27% lower resting
heart rate, and 21% lower body mass index than the sedentary
group (Table 1). Low-density lipoprotein cholesterol and
TABLE 1. Physical and physiological characteristics of subjects.
Trained Sedentary P value
Age (y) 23.5 6 0.9 25.4 6 1.2 NS
Height (cm) 182.6 6 2.4 183.9 6 3.7 NS
Weight (cm) 72.5 6 2.4 92.8 6 3.9 ,0.001
BMI (kgm22) 21.7 6 0.4 27.5 6 0.9 ,0.001
BSA (m2) 1.91 6 0.04 2.19 6 0.06 ,0.001
Resting heart rate (bmin21) 40 6 1 55 6 2 ,0.001
Maximal heart rate (bmin21) 197 6 2.5 203 6 3 NS
_Vo2max (mLkg21min21) 75.9 6 0.8 47.7 6 1.7 ,0.001
(mLkg20.75min21) 221 6 2.8 151 6 5.2 ,0.001
Systolic blood pressure (mm Hg) 122 6 2 128 6 3 NS
Diastolic blood pressure (mm Hg) 78 6 3 80 6 3 NS
Training (hy21) 640 6 24 55 6 14 ,0.001
High-intensity training sessions* 107 6 6 12 6 6 ,0.001
Hemoglobin (gdL21) 15.6 6 0.3 15.3 6 0.4 NS
Creatinine (mmolL21) 83 6 3.5 85 6 4.9 NS
Total cholesterol (mmolL21) 4.45 6 0.22 5.01 6 0.25 ,0.06
HDL cholesterol (mmolL21) 1.57 6 0. 08 1.24 6 0.11 ,0.02
LDL cholesterol (mmolL21) 2.41 6 0.22 3.01 6 0.24 ,0.07
Triglycerides (mmolL21) 1.0 6 0.2 1.7 6 0.3 ,0.03
Glucose (mmolL21) 4.9 6 0.2 5.1 6 0.1 NS
Hb A1c (%) 5.2 6 0.1 5.3 6 0.1 NS
Insulin C-peptide (nmolL21) 0.6 6 0.1 0.9 6 0.1 ,0.02
Ferritin (mgL21) 105 6 18 151 6 53 NS
Mean values 6 SEM.
BMI = body mass index; BSA = body surface area; _Vo2max = maximal oxygen uptake; HDL = high-density lipoprotein; LDL = low-
density lipoprotein; Hb A1c = glycolyzed hemoglobin A; NS = not statistically signiﬁcant.
*High-intensity training sessions per year was deﬁned as every session of exercise with.15minutes of training at an intensity of 85%
of maximal heart rate.
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triglycerides were 20% and 41% lower, whereas high-density
lipoprotein was 27% higher among the athletes (Table 1).
Resting and maximal arterial diameters measured 1 minute
after cuff release were 10–15% larger in the trained group
before exercise and 1 hour, 24 hours, and 48 hours after the
exercise session (Figure 2A, B). Peak blood ﬂow after cuff
release was 28–35% greater in athletes compared with
untrained subjects (Figure 2C, D). Despite lower peak blood
ﬂow, untrained subjects had approximately 18% higher peak
shear rate after cuff release at all time points compared with
athletes (750.9 6 11 vs. 640.2 6 14 s21; P , 0.01). There
were, however, no differences in FMD whether expressed in
absolute terms (Figure 2A, B) or in percentages (Figure 2E, F)
between groups at any time point, even when normalized to
shear stress (data not shown). A 38% reduction in FMD was
seen within the trained group 1 hour after exercise (Figure
2E, F). This postexercise reduction in FMD was accompa-
nied by 6% and 7% enlargements of the resting arterial
diameter among the trained sedentary groups, respectively
(Figure 2A). GTN-mediated dilatation was 17% in both
groups before exercise and did not differ within or between
groups throughout the study.
We observed a signiﬁcant inverse correlation between the
resting diameter before exercise and FMD (r = 20.48,
Figure 2. Brachial artery diameter (A, B), peak blood ﬂow (C, D), and ﬂow-mediated dilatation (FMD) (E, F) in endurance-trained and untrained men. *P , 0.02;
**P , 0.01 vs. baseline. +Larger in the trained group at all time points (P , 0.02).
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P , 0.05). Furthermore, our results showed a signiﬁcant
correlation between the resting diameters at baseline and
_Vo2max (r = 0.59, P , 0.02).
NO bioactivity did not differ between groups before the
exercise session (Figure 3A). The NO level was, however,
increased by 93% in the trained group and by 63% in the
sedentary group 1 hour after training (Figure 3A). Inter-
estingly, the NO bioactivity decreased to baseline level after
24 hours in the sedentary group but stayed elevated by 80%
above baseline after 24 hours and by 93% after 48 hours in
Figure 3.Nitric oxide bioactivity (A), total antioxidant status (B), low-density lipoproteins, and blood glucose levels measured before and after exercise. *P, 0.05;
**P , 0.02 vs. before exercise within groups.
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the trained group. Central to the regulation of endothelial
function is the bioavailability of NO, and abnormalities in one
or more pathways that ultimately regulate the availability of
NO, such as the level of blood glucose, triglycerides, and high-
and low-density lipoproteins, will inﬂuence endothelial
function. The level of triglycerides was lower and high-density
lipoproteins higher at all time points in the trained group
(baseline values shown in Table 1), whereas a single bout of
exercise signiﬁcantly reduced the level of low-density lip-
oproteins and blood glucose (Figure 3C, D). The circulating
antioxidant level was equal in the two groups before exercise
(Figure 3B) and increased by 7% and 10% 1 hour post exercise
in the sedentary and trained groups, respectively. The
antioxidant status returned to baseline 24 hours after exercise
in both groups and decreased to 5% below baseline (P, 0.05)
(Figure 2B) in the trained group after 48 hours.
DISCUSSION
The main ﬁnding in the present study is that highly
endurance-trained athletes had larger arterial diameter but
similar endothelial-dependent vasodilatationwhen compared
with untrained controls. Furthermore, we observed that the
FMD response to acute endurance exercise was highly
dependent on the time elapsed after exercise.
There were no signiﬁcant differences in FMD between the
groups at baseline. This indicates that the FMD, which is
believed to be mediated mainly by NO, is well preserved in
sedentary, young, healthy individuals and is not a limiting step
for delivering large amounts of blood to the exercising
musculature, as is the case during strenuous exercise. This is
somewhat surprising considering that an average maximal
oxygen uptake of 75.9 mLkg21min21 observed in the
athletes in the present study requires a substantial higher
cardiac output that has to be transported by the blood vessels
to the exercising muscles compared with a _Vo2max of 47.7
mLkg21min21 in untrained individuals (1).
In the present study, FMDmeasured 1 hour after the training
session was signiﬁcantly reduced compared with FMD at
baseline in the trained group, whereas baseline values were
observed 24 and 48 hours post exercise. This indicates
impaired endothelial function 1 hour after the training session
and normalizationwithin 24 hours. Reduced FMD1 hour post
training indicates that oxidative radicals cause local vascular
stress in the vessel during and after strenuous exercise. One
could expect that super oxide-anion will quench NO (22) but
that it will also combine with NO to form peroxynitrite (2),
a reactive nitrogen species that uncouples eNOS by oxidizing
the zinc-thiolate center, resulting in endothelial dysfunction
because of reduced bioavailability and production of NO,
respectively. However, in contrast to this, we observed
increased bioavailability of NO (Figure 2A) and improved
antioxidant status (Figure 2B) in blood samples taken 1 hour
post exercise, suggesting that mechanisms other than NO and
antioxidant levels are responsible for the transient decay in
FMD observed in the endurance athletes.
Interestingly, Silber et al. (23) demonstrated that arterial
FMD is linearly proportional to peak hyperemic shear stress
in normal subjects, i.e., the endothelial response is linearly
proportional to the stimulus. In line with this, we observed
a signiﬁcant inverse correlation between FMD and resting
arterial diameter (r = 20.51, P , 0.04) and support earlier
ﬁnding that larger arteries dilate less than smaller arteries
(4,6). The greater FMD response in small arteries may be
mediated, at least partially, by a greater hyperemic shear
stress. In line with this, Silber et al. (24) recently demo-
nstrated that the hyperemic shear stimulus for FMD was
greater in small arteries because of the dependence of
postischemic systolic ﬂow on radius squared. Therefore,
greater FMD in smaller arteries does not reﬂect better con-
duit artery endothelial function (24). Thus, it might be that
FMD in the untrained controls, who had smaller artery
diameters compared with the athletes, was overestimated.
However, even when we normalized for shear rate, we could
not observe any differences in FMD between the groups. The
reason for this may be either that the present test of endo-
thelial function is not sensitive enough to detect differences
between a normal and supranormal endothelial function, or
that a supranormal endothelial function not is necessary to
deliver large amounts of blood to exercising muscles. How-
ever, because of the signiﬁcantly larger diameter of the
brachial artery and a normal FMD, the athletes have a sub-
stantially higher capacity to transport large amounts of blood
during strenuous exercise compared with the untrained indi-
viduals, and as such they have improved ‘‘functional’’ endo-
thelial function. Another interesting aspect was the large
artery diameter observed in athletes 1 hour post exercise
combined with high levels of NO in plasma, which probably
dilated the vessel close to maximum, reducing the shear
stress imposed by reactive hyperemia, thus reducing FMD.
Recently, Hambrecht et al. (13) demonstrated twofold higher
eNOS and a fourfold higher eNOS Ser1177-phosphorylation
level in the left internal mammary artery after 4 weeks of
exercise training in patients with stable coronary artery
disease compared with sedentary controls. The Ser1177
residue seems to be a target for shear stress sensors, and
phosphorylation of Ser1177 leads to an increase in the enzyme
activity of eNOS and enhanced NO production (11). Thus,
exercise seems to have a dual positive effect by both
increased protein expression of eNOS, which may take a few
hours (9,11), and it enhances the phosphorylation of eNOS at
Ser1177 minutes after increased shear stress, thereby leading to
increased vascular NO production. Interestingly, the shear
stress-induced phosphorylation of eNOS is maintained (8),
whereas agonist-mediated Ser 1177 phosphorylation, such as
bradykinin, is only transient (10). Hambrecht et al. (13)
showed that exercise training has a larger impact on
phosphorylation of eNOS at Ser1177 than on the expression
of the eNOS protein itself. Sustained phosphorylation of
eNOS could explain sustained increased NO production in
athletes up to at least 48 hours post exercise. Furthermore,
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a sustained increased level of NO for at least 48 hours
occurred in conjunction with reduced levels of blood glucose
and low-density lipoproteins, both known to be inversely
related to the NO production. Interestingly, despite de-
creased levels of antioxidant capacity (i.e., increased level of
reactive oxygen species) 48 hours post exercise in athletes,
the bioavailability of NO remained 93% above baseline
values, suggesting that the transient decrease in antioxidant
status in athletes was physiologically insigniﬁcant.
Bergholm et al. (2) suggested that hard exercise may induce
oxidative stress that impairs the endothelial function. They
found that aerobic training (70–80% of _Vo2max) decreased
the circulating antioxidant level and impaired the endothelial
function in forearm vessels of healthy men after 4 weeks of
running training. Interestingly, Bergholm et al. (2) performed
the vascular measurements at least 36 hours after the last
training session. Accordingly, their data for oxidative stress ﬁt
with ours, but, in contrast to their study, we found unchanged
FMD and increased NO in blood at the same time point. The
reason for this remains unknown but could be related to
the much higher level of aerobic capacity in the athletes in
the present study.
Athletes had larger arteries compared with the sedentary
controls, and a large resting brachial artery diameter has been
shown to be an independent predictor of signiﬁcant coronary
arterial disease (15). However, a larger arterial diameter with
preserved function in athletes may be an analog to phys-
iological hypertrophy of the athlete’s heart with improved
function vs. pathological hypertrophy (i.e., observed in
patients with heart failure) with impaired function. Increased
arterial diameter on the basis of an exaggerated stimulated
production of NO in athletes suggests that a structural
enlargement of the artery has taken place in athletes. The
mechanisms responsible for mediating vascular structural
enlargement are not fully understood, but there is strong
evidence that NO plays an important part and that shear
stress is the trigging factor (28). However, it seems that
a larger brachial arterial diameter may be a stronger indicator
of improved endothelial function than FMD when compar-
ing highly trained and sedentary young subjects.
Low-density lipoprotein cholesterol and triglycerides were
signiﬁcantly higher in the sedentary group, whereas high-
density lipoprotein cholesterol was signiﬁcant higher in the
trained group. The mean values were all in the normal range.
In a recent study by our group, Moe et al. (19) reported no
difference in FMD between highly trained and sedentary
young women. The endurance-trained women had a higher
high-density lipoprotein cholesterol value but similar low-
density lipoprotein cholesterol and triglyceride values com-
pared with the sedentary group. Similarly, Taddei et al. (27)
reported the same endothelial function despite higher low-
density lipoprotein and lower high-density lipoprotein
cholesterol in a sedentary group compared with athletes
(approximate mean age 27 years). This suggests that blood
lipid values within the normal range do not affect the
endothelial function, although it may inﬂuence NO pro-
duction, as discussed above, in young, healthy subjects on
a short-term basis. These ﬁndings contrast those of Steinberg
et al. (26), who found that elevated cholesterol levels, even in
the high normal range, may be associated with endothelial
dysfunction. The mean age in Steinberg et al.’s study was
approximately 32 years, compared with approximately 24
years in our study. Thus, endothelial dysfunction may be
a long-term effect that is not apparent in early adulthood
among nonobese individuals. Kingwell et al. (17) showed
improved endothelial function in endurance athletes aged
approximately 35 years compared with age-matched seden-
tary men. A covariance analysis suggested that a lower total
cholesterol level in the trained group contributed to the
enhanced vasodilator response. This supports the hypothesis
that total cholesterol level inﬂuences the endothelial function
more with increasing age. Finally, De Souza et al. (7) reported
similar endothelial function and blood lipid proﬁles in
healthy sedentary men compared with trained young men.
The results of the present study suggest that endothelial
function iswell preserved in young, healthymen and that a high
aerobic training status because of long-term aerobic training
does not improve the dilating capacity. However, the trans-
porting capacity of blood is greater in athletes because of their
larger artery diameter. In addition, one strenuous high-intensity
exercise session does not seem to impair endothelial function.
PRACTICAL APPLICATIONS
The current study demonstrates that the differences in artery
diameter, not the ability of the vessel to dilate per se,
distinguish the enormous transport capacity of blood in
athletes’ arteries from that in normal healthy individuals.
Large arteries in athletes are linked to good function, whereas
large arteries in untrained subjects are linked to poor function.
Thus, ‘‘the athlete’s artery’’ is an analog to the athlete’s heart
with good function vs. the pathological hypertrophied heart
with poor function.
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